Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Tuberculosis

  Free Subscription


Articles published in Int J Tuberc Lung Dis

Retrieve available abstracts of 652 articles:
HTML format
Text format



Single Articles


    June 2018
  1. YABLONSKII PK, Avetisyan AO, Vasilev IV, Kudriashov GG, et al
    Robot-assisted lobectomy for pulmonary tuberculosis in a case with immunosuppression after kidney transplantation.
    Int J Tuberc Lung Dis. 2018;22:704-705.
    PubMed     Text format    


  2. SHIVAKUMAR SVBY, Chandrasekaran P, Kumar AMV, Paradkar M, et al
    Diabetes and pre-diabetes among household contacts of tuberculosis patients in India: is it time to screen them all?
    Int J Tuberc Lung Dis. 2018;22:686-694.
    PubMed     Text format     Abstract available


  3. CHIEN K, Seemangal J, Batt J, Vozoris NT, et al
    Abdominal tuberculosis: a descriptive case series of the experience in a Canadian tuberculosis clinic.
    Int J Tuberc Lung Dis. 2018;22:681-685.
    PubMed     Text format     Abstract available


  4. JACOBS MG, Pelissari DM, Pinto VL
    Factors associated with the drug-resistant tuberculosis incidence rate in Brazil.
    Int J Tuberc Lung Dis. 2018;22:675-680.
    PubMed     Text format     Abstract available


  5. LIU Y, Zheng Y, Chen J, Shi Y, et al
    Tuberculosis-associated mortality and its risk factors in a district of Shanghai, China: a retrospective cohort study.
    Int J Tuberc Lung Dis. 2018;22:655-660.
    PubMed     Text format     Abstract available


  6. MANSOUR O, Masini EO, Kim BJ, Kamene M, et al
    Impact of a national nutritional support programme on loss to follow-up after tuberculosis diagnosis in Kenya.
    Int J Tuberc Lung Dis. 2018;22:649-654.
    PubMed     Text format     Abstract available


  7. BOURGEOIS AC, Zulz T, Bruce MG, Stenz F, et al
    Tuberculosis in the Circumpolar Region, 2006-2012.
    Int J Tuberc Lung Dis. 2018;22:641-648.
    PubMed     Text format     Abstract available


  8. WANG KY, Lin YS, Sy CL, Huang WC, et al
    Hyperbaric oxygen therapy increases the risk of tuberculosis disease.
    Int J Tuberc Lung Dis. 2018;22:637-640.
    PubMed     Text format     Abstract available


  9. YANG ZH, Gorden T, Liu DP, Mukasa L, et al
    Increasing likelihood of advanced pulmonary tuberculosis at initial diagnosis in a low-incidence US state.
    Int J Tuberc Lung Dis. 2018;22:628-636.
    PubMed     Text format     Abstract available


  10. POPE V, Sacksteder KA, Hererra JC, Gilman RH, et al
    MPT64 patch test for the diagnosis of active pulmonary tuberculosis: a randomised controlled trial in Peru.
    Int J Tuberc Lung Dis. 2018;22:622-627.
    PubMed     Text format     Abstract available


  11. HORNE DJ, Jones BE, Kamada A, Fukushima K, et al
    Multicenter study of QuantiFERON((R))-TB Gold Plus in patients with active tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:617-621.
    PubMed     Text format     Abstract available


  12. WHITE RG, Charalambous S, Cardenas V, Hippner P, et al
    Evidence-informed policy making at country level: lessons learned from the South African Tuberculosis Think Tank.
    Int J Tuberc Lung Dis. 2018;22:606-613.
    PubMed     Text format     Abstract available


  13. DARA M, Zachariah R
    Hunger and tuberculosis: two sides of the same coin.
    Int J Tuberc Lung Dis. 2018;22:592.
    PubMed     Text format    


    May 2018
  14. KIM S, Seddon JA, Garcia-Prats AJ, Montepiedra G, et al
    Statistical considerations for pediatric multidrug-resistant tuberculosis efficacy trials.
    Int J Tuberc Lung Dis. 2018;22:34-39.
    PubMed     Text format     Abstract available


  15. GARCIA-PRATS AJ, Svensson EM, Weld ED, Schaaf HS, et al
    Current status of pharmacokinetic and safety studies of multidrug-resistant tuberculosis treatment in children.
    Int J Tuberc Lung Dis. 2018;22:15-23.
    PubMed     Text format     Abstract available


  16. TUCKER EW, Dooley KE
    Preclinical tools for the evaluation of tuberculosis treatment regimens for children.
    Int J Tuberc Lung Dis. 2018;22:7-14.
    PubMed     Text format     Abstract available


  17. JENKINS HE, Yuen CM
    The burden of multidrug-resistant tuberculosis in children.
    Int J Tuberc Lung Dis. 2018;22:3-6.
    PubMed     Text format     Abstract available


  18. LALOR MK, Mohiyuddin T, Uddin T, Thomas HL, et al
    The challenge of estimating tuberculosis mortality accurately in England and Wales.
    Int J Tuberc Lung Dis. 2018;22:572-578.
    PubMed     Text format     Abstract available


  19. MELENDEZ J, Hogeweg L, Sanchez CI, Philipsen RHHM, et al
    Accuracy of an automated system for tuberculosis detection on chest radiographs in high-risk screening.
    Int J Tuberc Lung Dis. 2018;22:567-571.
    PubMed     Text format     Abstract available


  20. KUHLIN J, Smith C, Khaemraev A, Tigay Z, et al
    Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan.
    Int J Tuberc Lung Dis. 2018;22:544-550.
    PubMed     Text format     Abstract available


  21. GGITA JM, Ojok C, Meyer AJ, Farr K, et al
    Patterns of usage and preferences of users for tuberculosis-related text messages and voice calls in Uganda.
    Int J Tuberc Lung Dis. 2018;22:530-536.
    PubMed     Text format     Abstract available


  22. MERID Y, Woldeamanuel Y, Abebe M, Datiko DG, et al
    High utility of active tuberculosis case finding in an Ethiopian prison.
    Int J Tuberc Lung Dis. 2018;22:524-529.
    PubMed     Text format     Abstract available


  23. KAWATSU L, Uchimura K, Izumi K, Ohkado A, et al
    Using surveillance data to simulate the impact of a hypothetical pre-entry tuberculosis screening programme in Japan.
    Int J Tuberc Lung Dis. 2018;22:510-517.
    PubMed     Text format     Abstract available


  24. SOHN H, Kim HY, Lee SH
    Cost-effectiveness of contact screening strategies for tuberculosis among high-school adolescents in South Korea.
    Int J Tuberc Lung Dis. 2018;22:496-503.
    PubMed     Text format     Abstract available


  25. BYAMUNGU LN, du Preez K, Walters E, Nachega JB, et al
    Timing of HIV diagnosis in children with tuberculosis managed at a referral hospital in Cape Town, South Africa.
    Int J Tuberc Lung Dis. 2018;22:488-495.
    PubMed     Text format     Abstract available


  26. GUPTA RK, Lipman M, Story A, Hayward A, et al
    Active case finding and treatment adherence in risk groups in the tuberculosis pre-elimination era.
    Int J Tuberc Lung Dis. 2018;22:479-487.
    PubMed     Text format     Abstract available


  27. VELASQUEZ GE, Davies GR, Mitnick CD
    Making up the difference: ensuring the bioequivalence of fixed-dose combinations for tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:473-474.
    PubMed     Text format    


    April 2018
  28. HARRIES AD
    Impact of antiretroviral therapy on tuberculosis control.
    Int J Tuberc Lung Dis. 2018;22:466-467.
    PubMed     Text format    


  29. PAYEN MC, De Wit S
    In Reply: Synergy between amoxicillin and meropenem/clavulanate in drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:465-466.
    PubMed     Text format    


  30. MISHRA GP, Caminero JA
    Low-dose amoxicillin-clavulanate in drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:465.
    PubMed     Text format    


  31. CLICK ES, Ouma GS, DeGruy K, Murithi W, et al
    No evidence of Mycobacterium tuberculosis in breast milk of 18 women with confirmed TB disease in Kisumu, Kenya.
    Int J Tuberc Lung Dis. 2018;22:464-465.
    PubMed     Text format    


  32. MATHYS V, Roycroft E, Raftery P, Groenheit R, et al
    Time-and-motion tool for the assessment of working time in tuberculosis laboratories: a multicentre study.
    Int J Tuberc Lung Dis. 2018;22:444-451.
    PubMed     Text format     Abstract available


  33. BASHAM CA, Elias B, Fanning A, Cook C, et al
    Performance measurement of a Canadian provincial tuberculosis programme: Manitoba, 2008-2012.
    Int J Tuberc Lung Dis. 2018;22:437-443.
    PubMed     Text format     Abstract available


  34. MASKERY B, Posey DL, Coleman MS, Asis R, et al
    Economic analysis of CDC's culture- and smear-based tuberculosis instructions for Filipino immigrants.
    Int J Tuberc Lung Dis. 2018;22:429-436.
    PubMed     Text format     Abstract available


  35. ADEPOYIBI T, Lilis L, Greb H, Boyle D, et al
    Which attributes within target product profiles for tuberculosis diagnostics are the most important to focus on?
    Int J Tuberc Lung Dis. 2018;22:425-428.
    PubMed     Text format     Abstract available


  36. YADAV R, Saini A, Kaur P, Behera D, et al
    Diagnostic accuracy of GenoType((R)) MTBDRsl VER 2.0 in detecting second-line drug resistance to M. tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:419-424.
    PubMed     Text format     Abstract available


  37. COX V, Brigden G, Crespo RH, Lessem E, et al
    Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:407-412.
    PubMed     Text format     Abstract available


  38. HEYCKENDORF J, van Leth F, Avsar K, Glattki G, et al
    Treatment responses in multidrug-resistant tuberculosis in Germany.
    Int J Tuberc Lung Dis. 2018;22:399-406.
    PubMed     Text format     Abstract available


  39. SCHNIPPEL K, Firnhaber C, Berhanu R, Page-Shipp L, et al
    Direct costs of managing adverse drug reactions during rifampicin-resistant tuberculosis treatment in South Africa.
    Int J Tuberc Lung Dis. 2018;22:393-398.
    PubMed     Text format     Abstract available


  40. HTET KKK, Soe KT, Kumar AMV, Saw S, et al
    Rifampicin-resistant tuberculosis patients in Myanmar in 2016: how many are lost on the path to treatment?
    Int J Tuberc Lung Dis. 2018;22:385-392.
    PubMed     Text format     Abstract available


  41. ONYOH EF, Kuaban C, Lin HH
    Pre-treatment loss to follow-up of pulmonary tuberculosis patients in two regions of Cameroon.
    Int J Tuberc Lung Dis. 2018;22:378-384.
    PubMed     Text format     Abstract available


  42. SHIN SS, Modongo C, Zetola NM, Wang Q, et al
    High rates of exposure to tuberculosis patients among HIV-infected health care workers in Botswana.
    Int J Tuberc Lung Dis. 2018;22:366-370.
    PubMed     Text format     Abstract available


    March 2018
  43. JACOBS C, Goussard P, Gie RP
    Mycobacterium tuberculosis, a cause of necrotising pneumonia in childhood: a case series.
    Int J Tuberc Lung Dis. 2018 Mar 22. doi: 10.5588/ijtld.17.0570.
    PubMed     Text format     Abstract available


  44. NAMIIRO S, Wobudeya E, Colebunders R, Worodria W, et al
    Molecular tests expedite the diagnosis of multidrug-resistant tuberculosis in childhood.
    Int J Tuberc Lung Dis. 2018;22:349-350.
    PubMed     Text format    


  45. BRUMWELL A, Noyes E, Kulkarni S, Lin V, et al
    A rapid review of treatment literacy materials for tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:336-341.
    PubMed     Text format     Abstract available


  46. BECKER AS, Bluthgen C, Phi van VD, Sekaggya-Wiltshire C, et al
    Detection of tuberculosis patterns in digital photographs of chest X-ray images using Deep Learning: feasibility study.
    Int J Tuberc Lung Dis. 2018;22:328-335.
    PubMed     Text format     Abstract available


  47. D'ATTILIO L, Diaz A, Fernandez RDV, Bongiovanni B, et al
    The neuro-endocrine-immune relationship in pulmonary and pleural tuberculosis: a better local profile in pleural fluid.
    Int J Tuberc Lung Dis. 2018;22:321-327.
    PubMed     Text format     Abstract available


  48. OLARU ID, Albert H, Zallet J, Werner UE, et al
    Impact of quality improvement in tuberculosis laboratories in low- and lower-middle-income countries: a systematic review.
    Int J Tuberc Lung Dis. 2018;22:309-320.
    PubMed     Text format     Abstract available


  49. BARK CM, Thiel BA, Ogwang S, Sekitoleko I, et al
    Sputum smear-positive, culture-negative state during anti-tuberculosis treatment in the MGIT liquid culture era.
    Int J Tuberc Lung Dis. 2018;22:306-308.
    PubMed     Text format     Abstract available


  50. FAN YM, Ding SP, Bao ZJ, Wu LM, et al
    Prognostic factors for treatment success in patients with multidrug-resistant tuberculosis in China.
    Int J Tuberc Lung Dis. 2018;22:300-305.
    PubMed     Text format     Abstract available


  51. FRANCIS JR, Manchikanti P, Blyth CC, Denholm J, et al
    Multidrug-resistant tuberculosis in Australia, 1998-2012.
    Int J Tuberc Lung Dis. 2018;22:294-299.
    PubMed     Text format     Abstract available


  52. SMITH CM, Lessells R, Grant AD, Herbst K, et al
    Spatial clustering of drug-resistant tuberculosis in Hlabisa subdistrict, KwaZulu-Natal, 2011-2015.
    Int J Tuberc Lung Dis. 2018;22:287-293.
    PubMed     Text format     Abstract available


  53. NGWIRA LG, Dowdy DW, Khundi M, Barnes GL, et al
    Delay in seeking care for tuberculosis symptoms among adults newly diagnosed with HIV in rural Malawi.
    Int J Tuberc Lung Dis. 2018;22:280-286.
    PubMed     Text format     Abstract available


  54. KWEZA PF, Van Schalkwyk C, Abraham N, Uys M, et al
    Estimating the magnitude of pulmonary tuberculosis patients missed by primary health care clinics in South Africa.
    Int J Tuberc Lung Dis. 2018;22:264-272.
    PubMed     Text format     Abstract available


  55. FURTADO DA LUZ E, Braga JU
    Under-reporting of tuberculosis in Praia, Cape Verde, from 2006 to 2012.
    Int J Tuberc Lung Dis. 2018;22:258-263.
    PubMed     Text format     Abstract available


  56. DAVIDSON JA, Fulton N, Thomas HL, Lalor MK, et al
    Investigating a tuberculosis cluster among Filipino health care workers in a low-incidence country.
    Int J Tuberc Lung Dis. 2018;22:252-257.
    PubMed     Text format     Abstract available


  57. VAN DEUN A, Decroo T, Piubello A, de Jong BC, et al
    Principles for constructing a tuberculosis treatment regimen: the role and definition of core and companion drugs.
    Int J Tuberc Lung Dis. 2018;22:239-245.
    PubMed     Text format     Abstract available


    February 2018
  58. ALSHEVSKAYA AA, Kireev FD, Laushkina ZA, Lopatnikova JA, et al
    Enhanced expression of TNF-alpha type-1 receptors by immune cells in active pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:212-220.
    PubMed     Text format     Abstract available


  59. BAIRD T, Donnan E, Coulter C, Simpson G, et al
    Multidrug-resistant tuberculosis in Queensland, Australia: an ongoing cross-border challenge.
    Int J Tuberc Lung Dis. 2018;22:206-211.
    PubMed     Text format     Abstract available


  60. PAVLENKO E, Barbova A, Hovhannesyan A, Tsenilova Z, et al
    Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey.
    Int J Tuberc Lung Dis. 2018;22:197-205.
    PubMed     Text format     Abstract available


  61. ANTHONY-WILLIAMS MH, Farrugia BB, Montefort S
    Tuberculosis notification and treatment outcome among migrant boat arrivals in Malta, 2007-2011.
    Int J Tuberc Lung Dis. 2018;22:194-196.
    PubMed     Text format     Abstract available


  62. TAHSEEN S, Shahnawaz H, Riaz U, Khanzada FM, et al
    Systematic case finding for tuberculosis in HIV-infected people who inject drugs: experience from Pakistan.
    Int J Tuberc Lung Dis. 2018;22:187-193.
    PubMed     Text format     Abstract available


  63. JIAMSAKUL A, Lee MP, Nguyen KV, Merati TP, et al
    Socio-economic status and risk of tuberculosis: a case-control study of HIV-infected patients in Asia.
    Int J Tuberc Lung Dis. 2018;22:179-186.
    PubMed     Text format     Abstract available


  64. DE CASTRO DB, Sadahiro M, Pinto RC, de Albuquerque BC, et al
    Spatial distribution of tuberculosis in Manaus and its social determinants, 2008-2013.
    Int J Tuberc Lung Dis. 2018;22:171-178.
    PubMed     Text format     Abstract available


  65. ROSSER A, Marx FM, Pareek M
    Recurrent tuberculosis in the pre-elimination era.
    Int J Tuberc Lung Dis. 2018;22:139-150.
    PubMed     Text format     Abstract available


  66. ODONE A, Roberts B, Dara M, van den Boom M, et al
    People- and patient-centred care for tuberculosis: models of care for tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:133-138.
    PubMed     Text format     Abstract available


    January 2018
  67. BYRNE AL, Marais BJ, Mitnick CD, Garden FL, et al
    Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru.
    Int J Tuberc Lung Dis. 2018;22:86-92.
    PubMed     Text format     Abstract available


  68. PINTO PFPS, Neto FC, de Almeida Ribeiro MCS
    Tuberculosis among South American immigrants in Sao Paulo municipality: an analysis in space and time.
    Int J Tuberc Lung Dis. 2018;22:80-85.
    PubMed     Text format     Abstract available


  69. WONG J, Lowenthal P, Flood J, Watt J, et al
    Increased tuberculosis risk among immigrants arriving in California with abnormal domestic chest radiographs.
    Int J Tuberc Lung Dis. 2018;22:73-79.
    PubMed     Text format     Abstract available


  70. SHIMAZAKI T, Taniguchi T, Saludar NRD, Gustilo LM, et al
    Bacterial co-infection and early mortality among pulmonary tuberculosis patients in Manila, The Philippines.
    Int J Tuberc Lung Dis. 2018;22:65-72.
    PubMed     Text format     Abstract available


  71. LEE B, Oh HJ, Chon BS
    Estimating the impact of a television campaign on tuberculosis knowledge and intention to test for TB in South Korea.
    Int J Tuberc Lung Dis. 2018;22:60-64.
    PubMed     Text format     Abstract available


  72. GUGLIELMETTI L, Veziris N, Aubry A, Brossier F, et al
    Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
    Int J Tuberc Lung Dis. 2018;22:54-59.
    PubMed     Text format     Abstract available


  73. EI PW, Aung WW, Nyunt WW, Swe TL, et al
    Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
    Int J Tuberc Lung Dis. 2018;22:47-53.
    PubMed     Text format     Abstract available


  74. LOVEDAY M, Sunkari B, Master I, Daftary A, et al
    Household context and psychosocial impact of childhood multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa.
    Int J Tuberc Lung Dis. 2018;22:40-46.
    PubMed     Text format     Abstract available


  75. PAYEN MC, Muylle I, Vandenberg O, Mathys V, et al
    Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases.
    Int J Tuberc Lung Dis. 2018;22:34-39.
    PubMed     Text format     Abstract available


  76. COURT R, Wiesner L, Stewart A, de Vries N, et al
    Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:30-33.
    PubMed     Text format     Abstract available


  77. LEE PH, Fu H, Lee MR, Magee M, et al
    Tuberculosis and diabetes in low and moderate tuberculosis incidence countries.
    Int J Tuberc Lung Dis. 2018;22:7-16.
    PubMed     Text format     Abstract available


  78. JACKSON C, Cohen T, Rangaka MX, Abubakar I, et al
    Eliminating tuberculosis in low-burden countries.
    Int J Tuberc Lung Dis. 2018;22:3.
    PubMed     Text format    


  79. ALFFENAAR JWC, Peloquin CA, Migliori GB
    Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone.
    Int J Tuberc Lung Dis. 2018;22:2.
    PubMed     Text format    


    December 2017
  80. NANSUMBA M, Kumbakumba E, Orikiriza P, Bastard M, et al
    Treatment outcomes and tolerability of the revised WHO anti-tuberculosis drug dosages for children.
    Int J Tuberc Lung Dis. 2017 Dec 20. doi: 10.5588/ijtld.17.0535.
    PubMed     Text format     Abstract available


  81. ALLWOOD BW, van Zyl-Smit R
    Tuberculosis, chronic obstructive pulmonary disease and inhaled corticosteroids: a complex web.
    Int J Tuberc Lung Dis. 2017;21:1317-1318.
    PubMed     Text format    


  82. ZELLWEGER JP
    Depression and risk of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1314.
    PubMed     Text format    


  83. YU ZG, Wang BZ, Li J, Ding ZL, et al
    Association between interleukin-17 genetic polymorphisms and tuberculosis susceptibility: an updated meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:1307-1313.
    PubMed     Text format     Abstract available


  84. SHU E, Sobieszczyk ME, Sal Y Rosas VG, Segura P, et al
    Knowledge of tuberculosis and vaccine trial preparedness in Lima, Peru.
    Int J Tuberc Lung Dis. 2017;21:1288-1293.
    PubMed     Text format     Abstract available


  85. MAVE V, Meshram S, Lokhande R, Kadam D, et al
    Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in Western India.
    Int J Tuberc Lung Dis. 2017;21:1280-1287.
    PubMed     Text format     Abstract available


  86. DELORY T, Ferrand H, Grall N, Casalino E, et al
    Score for pulmonary tuberculosis in patients with clinical presumption of tuberculosis in a low-prevalence area.
    Int J Tuberc Lung Dis. 2017;21:1272-1279.
    PubMed     Text format     Abstract available


  87. DALE K, Tay E, Trauer JM, Trevan P, et al
    Gender differences in tuberculosis diagnosis, treatment and outcomes in Victoria, Australia, 2002-2015.
    Int J Tuberc Lung Dis. 2017;21:1264-1271.
    PubMed     Text format     Abstract available


  88. KUMWENDA M, Nyang'wa BT, Chikuse B, Biseck T, et al
    The second sputum sample complicates tuberculosis diagnosis for women: a qualitative study from Malawi.
    Int J Tuberc Lung Dis. 2017;21:1258-1263.
    PubMed     Text format     Abstract available


  89. NAGU T, Ray R, Munseri P, Moshiro C, et al
    Tuberculosis among the elderly in Tanzania: disease presentation and initial response to treatment.
    Int J Tuberc Lung Dis. 2017;21:1251-1257.
    PubMed     Text format     Abstract available


  90. MOH R, Badje A, N'takpe JB, Kouame GM, et al
    Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults.
    Int J Tuberc Lung Dis. 2017;21:1237-1244.
    PubMed     Text format     Abstract available


  91. SURETTE MA, Beattie P, Nyirenda T, Olesen OF, et al
    Tackling tuberculosis in sub-Saharan Africa: EDCTP achievements and the road ahead.
    Int J Tuberc Lung Dis. 2017;21:1220-1229.
    PubMed     Text format     Abstract available


  92. HUANGFU P, Pearson F, Ugarte-Gil C, Critchley J, et al
    Diabetes and poor tuberculosis treatment outcomes: issues and implications in data interpretation and analysis.
    Int J Tuberc Lung Dis. 2017;21:1214-1219.
    PubMed     Text format     Abstract available


  93. COX V, Furin J
    World Health Organization recommendations for multidrug-resistant tuberculosis: should different standards be applied?
    Int J Tuberc Lung Dis. 2017;21:1211-1213.
    PubMed     Text format     Abstract available


    November 2017
  94. TREBUCQ A, Schwoebel V, Kashongwe Z, Bakayoko A, et al
    Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries.
    Int J Tuberc Lung Dis. 2017 Nov 17. doi: 10.5588/ijtld.17.0498.
    PubMed     Text format     Abstract available


  95. MAARTENS G, Brill MJE, Pandie M, Svensson EM, et al
    Pharmacokinetic interaction between bedaquiline and clofazimine in patients with drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017 Nov 16. doi: 10.5588/ijtld.17.0615.
    PubMed     Text format     Abstract available


  96. BOYD R, Ford N, Padgen P, Cox H, et al
    Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:1173-1180.
    PubMed     Text format     Abstract available


  97. MUCHENA G, Shambira G, Masuka N, Juru T, et al
    Determinants of multidrug resistance among previously treated tuberculosis patients in Zimbabwe, 2014.
    Int J Tuberc Lung Dis. 2017;21:1167-1172.
    PubMed     Text format     Abstract available


  98. GARCIA-GOEZ JF, Munera GA, Rojas V, Pacheco R, et al
    Tuberculosis in recipients of solid-organ transplants during 1995-2015 in Cali, Colombia.
    Int J Tuberc Lung Dis. 2017;21:1155-1159.
    PubMed     Text format     Abstract available


  99. KHAN PY, Crampin AC, Mzembe T, Koole O, et al
    Does antiretroviral treatment increase the infectiousness of smear-positive pulmonary tuberculosis?
    Int J Tuberc Lung Dis. 2017;21:1147-1154.
    PubMed     Text format     Abstract available


  100. RIVERA VR, Jean-Juste MA, Gluck SC, Reeder HT, et al
    Diagnostic yield of active case finding for tuberculosis and HIV at the household level in slums in Haiti.
    Int J Tuberc Lung Dis. 2017;21:1140-1146.
    PubMed     Text format     Abstract available


  101. CHEN C, Yang CG, Gao X, Lu ZZ, et al
    Community-based active case finding for tuberculosis in rural western China: a cross-sectional study.
    Int J Tuberc Lung Dis. 2017;21:1134-1139.
    PubMed     Text format     Abstract available


  102. MULDER C, Mgode GF, Ellis H, Valverde E, et al
    Accuracy of giant African pouched rats for diagnosing tuberculosis: comparison with culture and Xpert(R) MTB/RIF.
    Int J Tuberc Lung Dis. 2017;21:1127-1133.
    PubMed     Text format     Abstract available


  103. WELLS WA
    Onions and prevalence surveys: how to analyze and quantify tuberculosis case-finding gaps.
    Int J Tuberc Lung Dis. 2017;21:1101-1113.
    PubMed     Text format     Abstract available


  104. BAO J, Hafner R
    Conducting high-quality tuberculosis clinical trials in China: opportunities and challenges.
    Int J Tuberc Lung Dis. 2017;21:1094-1100.
    PubMed     Text format     Abstract available


  105. BORGDORFF MW, De Cock KM
    Provision of ART to individuals infected with HIV: impact on the epidemiology and control of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1091-1092.
    PubMed     Text format    


  106. MACINTYRE K, Bakker MI, Bergson S, Bhavaraju R, et al
    Defining the research agenda to measure and reduce tuberculosis stigmas.
    Int J Tuberc Lung Dis. 2017;21:87-96.
    PubMed     Text format     Abstract available


  107. SOMMERLAND N, Wouters E, Mitchell EMH, Ngicho M, et al
    Evidence-based interventions to reduce tuberculosis stigma: a systematic review.
    Int J Tuberc Lung Dis. 2017;21:81-86.
    PubMed     Text format     Abstract available


  108. SOMMERLAND N, Wouters E, Masquillier C, Engelbrecht M, et al
    Stigma as a barrier to the use of occupational health units for tuberculosis services in South Africa.
    Int J Tuberc Lung Dis. 2017;21:75-80.
    PubMed     Text format     Abstract available


  109. ZWERLING A, Dowdy D, von Delft A, Taylor H, et al
    Incorporating social justice and stigma in cost-effectiveness analysis: drug-resistant tuberculosis treatment.
    Int J Tuberc Lung Dis. 2017;21:69-74.
    PubMed     Text format     Abstract available


  110. BOND V, Floyd S, Fenty J, Schaap A, et al
    Secondary analysis of tuberculosis stigma data from a cluster randomised trial in Zambia and South Africa (ZAMSTAR).
    Int J Tuberc Lung Dis. 2017;21:49-59.
    PubMed     Text format     Abstract available


  111. MILLER C, Huston J, Samu L, Mfinanga S, et al
    'It makes the patient's spirit weaker': tuberculosis stigma and gender interaction in Dar es Salaam, Tanzania.
    Int J Tuberc Lung Dis. 2017;21:42-48.
    PubMed     Text format     Abstract available


    October 2017
  112. THAKUR C, Verma S, Negi RS, Kumar V, et al
    Lophomonas blattarum co-infection in a patient with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1185-1187.
    PubMed     Text format    


  113. NABIROVA D, Schmid G, Yusupova R, Kantarbayeva M, et al
    Assessment of the quality of anti-tuberculosis medicines in Almaty, Kazakhstan, 2014.
    Int J Tuberc Lung Dis. 2017;21:1161-1168.
    PubMed     Text format     Abstract available


  114. REDDY S, Ntoyanto S, Sakadavan Y, Reddy T, et al
    Detecting Mycobacterium tuberculosis using the loop-mediated isothermal amplification test in South Africa.
    Int J Tuberc Lung Dis. 2017;21:1154-1160.
    PubMed     Text format     Abstract available


  115. YADAV R, Sharma N, Khaneja R, Agarwal P, et al
    Evaluation of the TB-LAMP assay for the rapid diagnosis of pulmonary tuberculosis in Northern India.
    Int J Tuberc Lung Dis. 2017;21:1150-1153.
    PubMed     Text format     Abstract available


  116. LIANG L, Shi R, Liu X, Yuan X, et al
    Interferon-gamma response to the treatment of active pulmonary and extra-pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1145-1149.
    PubMed     Text format     Abstract available


  117. O'CONNOR DE, Frederix K, Saito S, Maama LB, et al
    Pulmonary tuberculosis diagnostic practices among people living with the human immunodeficiency virus in Lesotho.
    Int J Tuberc Lung Dis. 2017;21:1133-1138.
    PubMed     Text format     Abstract available


  118. SHARMA SK, Chaubey J, Singh BK, Sharma R, et al
    Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India.
    Int J Tuberc Lung Dis. 2017;21:1112-1117.
    PubMed     Text format     Abstract available


  119. SCHNIPPEL K, Firnhaber C, Ndjeka N, Conradie F, et al
    Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa.
    Int J Tuberc Lung Dis. 2017;21:1106-1111.
    PubMed     Text format     Abstract available


  120. MOHR E, Daniels J, Muller O, Furin J, et al
    Missed opportunities for earlier diagnosis of rifampicin-resistant tuberculosis despite access to Xpert(R) MTB/RIF.
    Int J Tuberc Lung Dis. 2017;21:1100-1105.
    PubMed     Text format     Abstract available


  121. JIANG Y, Cao B, Ohmagari N, Wu AH, et al
    Comprehensive understanding of health-seeking behaviour among pulmonary tuberculosis patients in China.
    Int J Tuberc Lung Dis. 2017;21:1094-1099.
    PubMed     Text format     Abstract available


  122. BROWN A, Ernst P, Cambule A, Morrow M, et al
    Applying the Care Group model to tuberculosis control: findings from a community-based project in Mozambique.
    Int J Tuberc Lung Dis. 2017;21:1086-1093.
    PubMed     Text format     Abstract available


  123. WILD V, Jaff D, Shah NS, Frick M, et al
    Tuberculosis, human rights and ethics considerations along the route of a highly vulnerable migrant from sub-Saharan Africa to Europe.
    Int J Tuberc Lung Dis. 2017;21:1075-1085.
    PubMed     Text format     Abstract available


  124. DENHOLM JT
    Strategic partnerships towards tuberculosis elimination.
    Int J Tuberc Lung Dis. 2017;21:1072.
    PubMed     Text format    


  125. VARAINE F
    Tuberculosis, human rights and ethics.
    Int J Tuberc Lung Dis. 2017;21:1071.
    PubMed     Text format    


    September 2017
  126. METCALFE J, Gerona R, Wen A, Bacchetti P, et al
    An LC-MS/MS-based method to analyze the anti-tuberculosis drug bedaquiline in hair.
    Int J Tuberc Lung Dis. 2017;21:1069-1070.
    PubMed     Text format    


  127. COLLINS D, Hafidz F, Mustikawati D
    The economic burden of tuberculosis in Indonesia.
    Int J Tuberc Lung Dis. 2017;21:1041-1048.
    PubMed     Text format     Abstract available


  128. MINH HV, Mai VQ, Nhung NV, Hoi LV, et al
    Costs of providing tuberculosis diagnosis and treatment services in Viet Nam.
    Int J Tuberc Lung Dis. 2017;21:1035-1040.
    PubMed     Text format     Abstract available


  129. DUNBAR R, Naidoo P, Beyers N, Langley I, et al
    High laboratory cost predicted per tuberculosis case diagnosed with increased case finding without a triage strategy.
    Int J Tuberc Lung Dis. 2017;21:1026-1034.
    PubMed     Text format     Abstract available


  130. NATHAVITHARANA RR, Daru P, Barrera AE, Mostofa Kamal SM, et al
    FAST implementation in Bangladesh: high frequency of unsuspected tuberculosis justifies challenges of scale-up.
    Int J Tuberc Lung Dis. 2017;21:1020-1025.
    PubMed     Text format     Abstract available


  131. YOON C, Chaisson LH, Patel SM, Allen IE, et al
    Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:1013-1019.
    PubMed     Text format     Abstract available


  132. DATIKO DG, Yassin MA, Theobald SJ, Cuevas LE, et al
    A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia.
    Int J Tuberc Lung Dis. 2017;21:1002-1007.
    PubMed     Text format     Abstract available


  133. LIAO S, Cai C, Huo FM, Wu JN, et al
    Trends in drug-resistant tuberculosis in China: data from a clinical tuberculosis centre.
    Int J Tuberc Lung Dis. 2017;21:990-995.
    PubMed     Text format     Abstract available


  134. ZENNER D, Hafezi H, Potter J, Capone S, et al
    Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.
    Int J Tuberc Lung Dis. 2017;21:965-976.
    PubMed     Text format     Abstract available


  135. PEDRAZZOLI D, Boccia D, Dodd PJ, Lonnroth K, et al
    Modelling the social and structural determinants of tuberculosis: opportunities and challenges.
    Int J Tuberc Lung Dis. 2017;21:957-964.
    PubMed     Text format     Abstract available


  136. CENTIS R, D'Ambrosio L, Migliori GB
    Understanding the multidrug-resistant tuberculosis epidemic in China.
    Int J Tuberc Lung Dis. 2017;21:955.
    PubMed     Text format    


    August 2017
  137. THOMAS B, Watson B, Senthil EK, Deepalakshmi A, et al
    Alcohol intervention strategy among tuberculosis patients: a pilot study from South India.
    Int J Tuberc Lung Dis. 2017;21:947-952.
    PubMed     Text format     Abstract available


  138. DESHMUKH PR, Mundra A, Dawale A
    Social capital and adverse treatment outcomes of tuberculosis: a case-control study.
    Int J Tuberc Lung Dis. 2017;21:941-946.
    PubMed     Text format     Abstract available


  139. RODRIGUEZ CA, Sasse S, Yuengling KA, Azzawi S, et al
    A systematic review of national policies for the management of persons exposed to tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:935-940.
    PubMed     Text format     Abstract available


  140. SOUSA M, Gomes M, Gaio AR, Duarte R, et al
    Nosocomial tuberculosis prevention in Portuguese hospitals: a cross-sectional evaluation.
    Int J Tuberc Lung Dis. 2017;21:930-934.
    PubMed     Text format     Abstract available


  141. MCDANIEL CJ, Chitnis AS, Barry PM, Shah N, et al
    Tuberculosis trends in California correctional facilities, 1993-2013.
    Int J Tuberc Lung Dis. 2017;21:922-929.
    PubMed     Text format     Abstract available


  142. RAJAN JV, Ferrazoli L, Waldman EA, Simonsen V, et al
    Diabetes increases the risk of recent-transmission tuberculosis in household contacts in Sao Paulo, Brazil.
    Int J Tuberc Lung Dis. 2017;21:916-921.
    PubMed     Text format     Abstract available


  143. MEHRA M, Kambili C, Potluri R, Rhines A, et al
    Modeling the impact of bedaquiline treatment strategies on the multidrug-resistant tuberculosis burden in India.
    Int J Tuberc Lung Dis. 2017;21:902-909.
    PubMed     Text format     Abstract available


  144. CALDERON RI, Velasquez GE, Becerra MC, Zhang Z, et al
    Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru.
    Int J Tuberc Lung Dis. 2017;21:894-901.
    PubMed     Text format     Abstract available


  145. MELENDEZ J, Philipsen RHHM, Chanda-Kapata P, Sunkutu V, et al
    Automatic versus human reading of chest X-rays in the Zambia National Tuberculosis Prevalence Survey.
    Int J Tuberc Lung Dis. 2017;21:880-886.
    PubMed     Text format     Abstract available


  146. BONNET M, Kyakwera C, Kyomugasho N, Atwine D, et al
    Prospective cohort study of the feasibility and yield of household child tuberculosis contact screening in Uganda.
    Int J Tuberc Lung Dis. 2017;21:862-868.
    PubMed     Text format     Abstract available


  147. SWEETLAND AC, Kritski A, Oquendo MA, Sublette ME, et al
    Addressing the tuberculosis-depression syndemic to end the tuberculosis epidemic.
    Int J Tuberc Lung Dis. 2017;21:852-861.
    PubMed     Text format     Abstract available


  148. KUNST H, Burman M, Arnesen TM, Fiebig L, et al
    Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results.
    Int J Tuberc Lung Dis. 2017;21:840-851.
    PubMed     Text format     Abstract available


  149. SHAKOOR S, Hasan R
    Strategies for management of latent tuberculosis in endemic settings: building evidence.
    Int J Tuberc Lung Dis. 2017;21:836.
    PubMed     Text format    


  150. ZELLWEGER JP, Posey DL
    Migrant screening for tuberculosis and LTBI in Europe.
    Int J Tuberc Lung Dis. 2017;21:835.
    PubMed     Text format    


  151. WANG XH, Ma AG, Han XX, Chen L, et al
    Relationship between Toll-like receptor 4 and type-2 diabetes mellitus complicated by tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:910-915.
    PubMed     Text format     Abstract available


    July 2017
  152. HARRIES AD, Ade S, Hoa NB, Satyanarayana S, et al
    Use of inhaled corticosteroids for obstructive lung disease following anti-tuberculosis treatment.
    Int J Tuberc Lung Dis. 2017;21:833-834.
    PubMed     Text format    


  153. MOHAMED EI, Mohamed MA, Moustafa MH, Abdel-Mageed SM, et al
    Qualitative analysis of biological tuberculosis samples by an electronic nose-based artificial neural network.
    Int J Tuberc Lung Dis. 2017;21:810-817.
    PubMed     Text format     Abstract available


  154. OH KH, Choi H, Kim EJ, Kim HJ, et al
    Depression and risk of tuberculosis: a nationwide population-based cohort study.
    Int J Tuberc Lung Dis. 2017;21:804-809.
    PubMed     Text format     Abstract available


  155. NERY JS, Rodrigues LC, Rasella D, Aquino R, et al
    Effect of Brazil's conditional cash transfer programme on tuberculosis incidence.
    Int J Tuberc Lung Dis. 2017;21:790-796.
    PubMed     Text format     Abstract available


  156. APOLINARIO D, Ribeiro AI, Krainski E, Sousa P, et al
    Tuberculosis inequalities and socio-economic deprivation in Portugal.
    Int J Tuberc Lung Dis. 2017;21:784-789.
    PubMed     Text format     Abstract available


  157. ZHU L, Yang YZ, Guan HY, Cheng SM, et al
    Trends in drug-resistant tuberculosis after the implementation of the DOTS strategy in Shenzhen, China, 2000-2013.
    Int J Tuberc Lung Dis. 2017;21:759-765.
    PubMed     Text format     Abstract available


  158. THI SS, Parker DM, Swe LL, Pukrittayakamee S, et al
    Migration histories of multidrug-resistant tuberculosis patients from the Thailand-Myanmar border, 2012-2014.
    Int J Tuberc Lung Dis. 2017;21:753-758.
    PubMed     Text format     Abstract available


  159. SHETE PB, Nalugwa T, Farr K, Ojok C, et al
    Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy.
    Int J Tuberc Lung Dis. 2017;21:746-752.
    PubMed     Text format     Abstract available


  160. DOUGLAS P, Posey DL, Zenner D, Robson J, et al
    Capacity strengthening through pre-migration tuberculosis screening programmes: IRHWG experiences.
    Int J Tuberc Lung Dis. 2017;21:737-745.
    PubMed     Text format     Abstract available


  161. DARA M, Sulis G, Centis R, D'Ambrosio L, et al
    Cross-border collaboration for improved tuberculosis prevention and care: policies, tools and experiences.
    Int J Tuberc Lung Dis. 2017;21:727-736.
    PubMed     Text format     Abstract available


  162. KUNST H
    Cross-border collaboration in tuberculosis prevention and care in Europe: can we do better?
    Int J Tuberc Lung Dis. 2017;21:717.
    PubMed     Text format    


    June 2017
  163. MAGEE MJ, Darchia L, Kipiani M, Chakhaia T, et al
    Smoking behavior and beliefs about the impact of smoking on anti-tuberculosis treatment among health care workers.
    Int J Tuberc Lung Dis. 2017 Jun 29. doi: 10.5588/ijtld.17.0023.
    PubMed     Text format     Abstract available


  164. DELGADO E, Monedero I, Bhavaraju R
    Resilience and extensively drug-resistant tuberculosis: the unlikely ally.
    Int J Tuberc Lung Dis. 2017;21:713-716.
    PubMed     Text format     Abstract available


  165. SIVAKUMAR P, Marples L, Breen R, Ahmed L, et al
    The diagnostic utility of pleural fluid adenosine deaminase for tuberculosis in a low prevalence area.
    Int J Tuberc Lung Dis. 2017;21:697-701.
    PubMed     Text format     Abstract available


  166. TELISINGHE L, Amofa-Sekyi M, Maluzi K, Kaluba-Milimo D, et al
    The sensitivity of the QuantiFERON(R)-TB Gold Plus assay in Zambian adults with active tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:690-696.
    PubMed     Text format     Abstract available


  167. BARR DA, Coussens AK, Irvine S, Ritchie ND, et al
    Paradoxical upgrading reaction in extra-pulmonary tuberculosis: association with vitamin D therapy.
    Int J Tuberc Lung Dis. 2017;21:677-683.
    PubMed     Text format     Abstract available


  168. VAN DER HEIJDEN YF, Karim F, Mufamadi G, Zako L, et al
    Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa.
    Int J Tuberc Lung Dis. 2017;21:670-676.
    PubMed     Text format     Abstract available


  169. PATSCHE CB, Rudolf F, Mogensen SW, Sifna A, et al
    Low prevalence of malnourishment among household contacts of patients with tuberculosis in Guinea-Bissau.
    Int J Tuberc Lung Dis. 2017;21:664-669.
    PubMed     Text format     Abstract available


  170. STENNIS NL, Meissner JS, Bhavnani D, Kreiswirth B, et al
    Tuberculosis disease among Mexico-born individuals living in New York City, 2001-2014.
    Int J Tuberc Lung Dis. 2017;21:657-663.
    PubMed     Text format     Abstract available


  171. SNOW K, Hesseling AC, Naidoo P, Graham SM, et al
    Tuberculosis in adolescents and young adults: epidemiology and treatment outcomes in the Western Cape.
    Int J Tuberc Lung Dis. 2017;21:651-657.
    PubMed     Text format     Abstract available


  172. KALRA A
    Care seeking and treatment related delay among childhood tuberculosis patients in Delhi, India.
    Int J Tuberc Lung Dis. 2017;21:645-650.
    PubMed     Text format     Abstract available


  173. ZIEMELE B, Ranka R, Ozere I
    Pediatric and adolescent tuberculosis in Latvia, 2011-2014: case detection, diagnosis and treatment.
    Int J Tuberc Lung Dis. 2017;21:637-645.
    PubMed     Text format     Abstract available


  174. LONNROTH K, Mor Z, Erkens C, Bruchfeld J, et al
    Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points.
    Int J Tuberc Lung Dis. 2017;21:624-637.
    PubMed     Text format     Abstract available


  175. DHAVAN P, Dias HM, Creswell J, Weil D, et al
    An overview of tuberculosis and migration.
    Int J Tuberc Lung Dis. 2017;21:610-623.
    PubMed     Text format     Abstract available


  176. WALKER IF, Baral SC, Wei X, Huque R, et al
    Multidrug-resistant tuberculosis treatment programmes insufficiently consider comorbid mental disorders.
    Int J Tuberc Lung Dis. 2017;21:603-609.
    PubMed     Text format     Abstract available


  177. SEDDON JA, Gie RP
    If you look, you will find: time to challenge the childhood tuberculosis paradigm.
    Int J Tuberc Lung Dis. 2017;21:602.
    PubMed     Text format    


  178. RAVIGLIONE MC, Mosca D
    Migrant health and tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:599-600.
    PubMed     Text format    


  179. OWUSU-EDUSEI K, Stockbridge EL, Winston CA, Kolasa M, et al
    Tuberculin skin test and interferon-gamma release assay use among privately insured persons in the United States.
    Int J Tuberc Lung Dis. 2017;21:684-689.
    PubMed     Text format     Abstract available


    May 2017
  180. J-Y FENG JY, Jarlsberg LG, Salcedo K, Rose J, et al
    Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017 May 16. doi: 10.5588/ijtld.16.0510.
    PubMed     Text format     Abstract available


  181. ARSCOTT-MILLS T, Masole L, Ncube R, Steenhoff AP, et al
    Survey of health care worker knowledge about childhood tuberculosis in high-burden centers in Botswana.
    Int J Tuberc Lung Dis. 2017;21:586-591.
    PubMed     Text format     Abstract available


  182. SCOTT C, Mangan J, Tillova Z, Jensen PA, et al
    Evaluation of the Tuberculosis Infection Control Training Center, Tajikistan, 2014-2015.
    Int J Tuberc Lung Dis. 2017;21:579-585.
    PubMed     Text format     Abstract available


  183. ADAMS LV, Basu D, Grande SW, Craig SR, et al
    Barriers to tuberculosis care delivery among miners and their families in South Africa: an ethnographic study.
    Int J Tuberc Lung Dis. 2017;21:571-578.
    PubMed     Text format     Abstract available


  184. UKWAJA KN, Alobu I, Gidado M, Onazi O, et al
    Economic support intervention improves tuberculosis treatment outcomes in rural Nigeria.
    Int J Tuberc Lung Dis. 2017;21:564-570.
    PubMed     Text format     Abstract available


  185. LOVEDAY M, Ramjee A, Osburn G, Master I, et al
    Drug-resistant tuberculosis in patients with minimal symptoms: favourable outcomes in the absence of treatment.
    Int J Tuberc Lung Dis. 2017;21:556-563.
    PubMed     Text format     Abstract available


  186. DALE KD, Globan M, Tay EL, Trauer JM, et al
    Recurrence of tuberculosis in a low-incidence setting without directly observed treatment: Victoria, Australia, 2002-2014.
    Int J Tuberc Lung Dis. 2017;21:550-555.
    PubMed     Text format     Abstract available


  187. MAHARAJ B, Gengiah TN, Yende-Zuma N, Gengiah S, et al
    Implementing isoniazid preventive therapy in a tuberculosis treatment-experienced cohort on ART.
    Int J Tuberc Lung Dis. 2017;21:537-543.
    PubMed     Text format     Abstract available


  188. SSENGOOBA W, Lukoye D, Meehan CJ, Kateete DP, et al
    Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda.
    Int J Tuberc Lung Dis. 2017;21:531-536.
    PubMed     Text format     Abstract available


  189. SATAKE Y, Nakamura Y, Kono M, Hozumi H, et al
    Type-1 polarised dendritic cells are a potent immunogen against Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:523-530.
    PubMed     Text format     Abstract available


  190. RONALD LA, Ling DI, FitzGerald JM, Schwartzman K, et al
    Validated methods for identifying tuberculosis patients in health administrative databases: systematic review.
    Int J Tuberc Lung Dis. 2017;21:517-522.
    PubMed     Text format     Abstract available


  191. FENG JY, Jarlsberg LG, Rose J, Grinsdale JA, et al
    Impact of Euro-American sublineages of Mycobacterium tuberculosis on new infections among named contacts.
    Int J Tuberc Lung Dis. 2017;21:509-516.
    PubMed     Text format     Abstract available


  192. HO J, Jelfs P, Nguyen PT, Sintchenko V, et al
    Pooling sputum samples to improve the feasibility of Xpert(R) MTB/RIF in systematic screening for tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:503-508.
    PubMed     Text format     Abstract available


  193. VAN AART C, Boshuizen H, Dekkers A, Korthals Altes H, et al
    Time lag between immigration and tuberculosis rates in immigrants in the Netherlands: a time-series analysis.
    Int J Tuberc Lung Dis. 2017;21:486-492.
    PubMed     Text format     Abstract available


  194. POSEY DL, Marano N, Cetron MS
    Cross-border solutions needed to address tuberculosis in migrating populations.
    Int J Tuberc Lung Dis. 2017;21:485-486.
    PubMed     Text format    


  195. YATES TA, Atkinson SH
    Ironing out sex differences in tuberculosis prevalence.
    Int J Tuberc Lung Dis. 2017;21:483-484.
    PubMed     Text format    


  196. WORTHAM JM, Goggin M, Mora C, Vandehey L, et al
    Acute kidney injury during treatment for latent tuberculous infection with rifampin.
    Int J Tuberc Lung Dis. 2017;21:596-597.
    PubMed     Text format     Abstract available


  197. LANGE B, Khan P, Kalmambetova G, Al-Darraji HA, et al
    Diagnostic accuracy of the Xpert((R)) MTB/RIF cycle threshold level to predict smear positivity: a meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:493-502.
    PubMed     Text format     Abstract available


    April 2017
  198. JAIN A, Singh PK, Singh U, Kumar V, et al
    Initial screening of extra-pulmonary tuberculosis using the Xpert MTB/RIF assay improves case detection rates.
    Int J Tuberc Lung Dis. 2017;21:478-480.
    PubMed     Text format    


  199. CHONG SG, Herron M, Dorman A, Little M, et al
    Renal amyloidosis complicating multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:476-477.
    PubMed     Text format    


  200. BLOK L, Bakker MI, Straetemans M, Gerstel L, et al
    Should active case-finding projects increase the number of tuberculosis cases notified at national level?
    Int J Tuberc Lung Dis. 2017;21:475.
    PubMed     Text format    


  201. WEBER SF, Belard S, Rai S, Reddy R, et al
    Immune thrombocytopenia secondary to tuberculosis: a case and review of literature.
    Int J Tuberc Lung Dis. 2017;21:466-470.
    PubMed     Text format     Abstract available


  202. VALENCIA S, Respeito D, Blanco S, Ribeiro RM, et al
    Tuberculosis drug resistance in Southern Mozambique: results of a population-level survey in the district of Manhica.
    Int J Tuberc Lung Dis. 2017;21:446-451.
    PubMed     Text format     Abstract available


  203. ADLER H, Archary M, Mahabeer P, LaRussa P, et al
    Tuberculosis in HIV-infected South African children with complicated severe acute malnutrition.
    Int J Tuberc Lung Dis. 2017;21:438-445.
    PubMed     Text format     Abstract available


  204. CARTER KL, Gabrellas AD, Shah S, Garland JM, et al
    Improved latent tuberculosis therapy completion rates in refugee patients through use of a clinical pharmacist.
    Int J Tuberc Lung Dis. 2017;21:432-437.
    PubMed     Text format     Abstract available


  205. ARMENTA RF, Collins KM, Strathdee SA, Bulterys MA, et al
    Mycobacterium tuberculosis infection among persons who inject drugs in San Diego, California.
    Int J Tuberc Lung Dis. 2017;21:425-431.
    PubMed     Text format     Abstract available


  206. SHAIKH N, Gupte A, Dharmshale S, Pokkali S, et al
    Novel interferon-gamma assays for diagnosing tuberculosis in young children in India.
    Int J Tuberc Lung Dis. 2017;21:412-419.
    PubMed     Text format     Abstract available


  207. VAN WYK SS, Lin HH, Claassens MM
    A systematic review of prediction models for prevalent pulmonary tuberculosis in adults.
    Int J Tuberc Lung Dis. 2017;21:405-411.
    PubMed     Text format     Abstract available


  208. OWUSU-EDUSEI K, Marks SM, Miramontes R, Stockbridge EL, et al
    Tuberculosis hospitalization expenditures per patient from private health insurance claims data, 2010-2014.
    Int J Tuberc Lung Dis. 2017;21:398-404.
    PubMed     Text format     Abstract available


  209. RUPERT S, Vassall A, Raizada N, Khaparde SD, et al
    Bottom-up or top-down: unit cost estimation of tuberculosis diagnostic tests in India.
    Int J Tuberc Lung Dis. 2017;21:375-380.
    PubMed     Text format     Abstract available


  210. PANDEY S, Chadha VK, Laxminarayan R, Arinaminpathy N, et al
    Estimating tuberculosis incidence from primary survey data: a mathematical modeling approach.
    Int J Tuberc Lung Dis. 2017;21:366-374.
    PubMed     Text format     Abstract available


  211. DODD PJ
    Tracking tuberculosis incidence: time to tool up.
    Int J Tuberc Lung Dis. 2017;21:363.
    PubMed     Text format    


  212. ADINARAYANAN S, Culp RK, Subramani R, Abbas KM, et al
    Role of bacille Calmette-Guerin in preventing tuberculous infection.
    Int J Tuberc Lung Dis. 2017;21:420-424.
    PubMed     Text format     Abstract available


  213. ACUNA-VILLAORDUNA C, Orikiriza P, Nyehangane D, White LF, et al
    Effect of previous treatment and sputum quality on diagnostic accuracy of Xpert((R)) MTB/RIF.
    Int J Tuberc Lung Dis. 2017;21:389-397.
    PubMed     Text format     Abstract available


  214. DUNBAR R, Naidoo P, Beyers N, Langley I, et al
    Operational modelling: the mechanisms influencing TB diagnostic yield in an Xpert((R)) MTB/RIF-based algorithm.
    Int J Tuberc Lung Dis. 2017;21:381-388.
    PubMed     Text format     Abstract available


    March 2017
  215. ZHANG ZX, Sng LH, Yong Y, Lin LM, et al
    Delays in diagnosis and treatment of pulmonary tuberculosis in AFB smear-negative patients with pneumonia.
    Int J Tuberc Lung Dis. 2017 Mar 16. doi: 10.5588/ijtld.16.0667.
    PubMed     Text format     Abstract available


  216. MASJEDI MR, Hosseini M, Aryanpur M, Mortaz E, et al
    The effects of smoking on treatment outcome in patients newly diagnosed with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:351-356.
    PubMed     Text format     Abstract available


  217. BOONYAGARS L, Hirunwiwatkul P, Hurst CP
    CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
    Int J Tuberc Lung Dis. 2017;21:338-344.
    PubMed     Text format     Abstract available


  218. DIAS M, Gaio R, Sousa P, Abranches M, et al
    Tuberculosis among the homeless: should we change the strategy?
    Int J Tuberc Lung Dis. 2017;21:327-332.
    PubMed     Text format     Abstract available


  219. O'HARA LM, Yassi A, Bryce EA, van Rensburg AJ, et al
    Infection control and tuberculosis in health care workers: an assessment of 28 hospitals in South Africa.
    Int J Tuberc Lung Dis. 2017;21:320-326.
    PubMed     Text format     Abstract available


  220. HUERGA H, Bastard M, Kamene M, Wanjala S, et al
    Outcomes from the first multidrug-resistant tuberculosis programme in Kenya.
    Int J Tuberc Lung Dis. 2017;21:314-319.
    PubMed     Text format     Abstract available


  221. JAVAID A, Hasan R, Zafar A, Chaudry MA, et al
    Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
    Int J Tuberc Lung Dis. 2017;21:303-308.
    PubMed     Text format     Abstract available


  222. FOX GJ, Anh NT, Nhung NV, Loi NT, et al
    Latent tuberculous infection in household contacts of multidrug-resistant and newly diagnosed tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:297-302.
    PubMed     Text format     Abstract available


  223. KAMAKIA R, Kiazyk S, Waruk J, Meyers A, et al
    Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:278-285.
    PubMed     Text format     Abstract available


  224. NAUSCH N, Lundtoft C, Schulz G, Henckel H, et al
    Multiple cytokines for the detection of Mycobacterium tuberculosis infection in children with tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:270-277.
    PubMed     Text format     Abstract available


  225. DONNAN EJ, Coulter C, Simpson G, Clark J, et al
    Paediatric tuberculosis in Queensland, Australia: overrepresentation of cross-border and Indigenous children.
    Int J Tuberc Lung Dis. 2017;21:263-269.
    PubMed     Text format     Abstract available


  226. CRANMER LM, Langat A, Ronen K, McGrath CJ, et al
    Integrating tuberculosis screening in Kenyan Prevention of Mother-To-Child Transmission programs.
    Int J Tuberc Lung Dis. 2017;21:256-262.
    PubMed     Text format     Abstract available


  227. REICHMAN LB
    The tuberculosis taboo.
    Int J Tuberc Lung Dis. 2017;21:251-255.
    PubMed     Text format     Abstract available


  228. KURBANIYAZOVA G, Joncevska M, Kalon S, Kalmambetova G, et al
    Results of Xpert((R)) MTB/RIF implementation in Kyrgyzstan.
    Int J Tuberc Lung Dis. 2017;21:333-337.
    PubMed     Text format     Abstract available


  229. ANASTASAKOS V, Skouras V, Moschos C, Tsikrika S, et al
    Patterns of drug resistance among patients with tuberculous pleural effusion in Greece.
    Int J Tuberc Lung Dis. 2017;21:309-313.
    PubMed     Text format     Abstract available


  230. MORO RN, Sterling TR, Saukkonen J, Vernon A, et al
    Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial.
    Int J Tuberc Lung Dis. 2017;21:286-296.
    PubMed     Text format     Abstract available


    February 2017
  231. PRIYADARSHINI P, Tiwari K, Das A, Kumar D, et al
    Evaluation of highly conserved hsp65-specific nested PCR primers for diagnosing Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:214-217.
    PubMed     Text format     Abstract available


  232. MCEBULA V, Crowther NJ, Nagel SE, George JA, et al
    Diabetes and abnormal glucose tolerance in subjects with tuberculosis in a South African urban center.
    Int J Tuberc Lung Dis. 2017;21:208-213.
    PubMed     Text format     Abstract available


  233. BRYLA M, Dziankowska-Zaborszczyk E, Maniecka-Bryla I
    Standard expected years of life lost due to tuberculosis in Poland.
    Int J Tuberc Lung Dis. 2017;21:202-207.
    PubMed     Text format     Abstract available


  234. CLAASSENS MM, Dunbar R, Yang B, Lombard CJ, et al
    Scanty smears associated with initial loss to follow-up in South African tuberculosis patients.
    Int J Tuberc Lung Dis. 2017;21:196-201.
    PubMed     Text format     Abstract available


  235. IZUMI K, Ohkado A, Uchimura K, Kawatsu L, et al
    Evaluation of tuberculosis contact investigations in Japan.
    Int J Tuberc Lung Dis. 2017;21:188-195.
    PubMed     Text format     Abstract available


  236. HTET KK, Liabsuetrakul T, Thein S
    Cost-effectiveness of a new strategy to detect pulmonary tuberculosis in household contacts in Myanmar.
    Int J Tuberc Lung Dis. 2017;21:181-187.
    PubMed     Text format     Abstract available


  237. GUGLIELMETTI L, Hewison C, Avaliani Z, Hughes J, et al
    Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries.
    Int J Tuberc Lung Dis. 2017;21:167-174.
    PubMed     Text format     Abstract available


  238. CHIPINDURO M, Mateveke K, Makamure B, Ferrand RA, et al
    Stool Xpert(R) MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis at primary clinics in Zimbabwe.
    Int J Tuberc Lung Dis. 2017;21:161-166.
    PubMed     Text format     Abstract available


  239. CHIANG SS, Roche S, Contreras C, Del Castillo H, et al
    Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study.
    Int J Tuberc Lung Dis. 2017;21:154-160.
    PubMed     Text format     Abstract available


  240. LOPEZ C, Bertram-Farough A, Heywood D, Dawson L, et al
    Knowing about you: eliciting dimensions of personhood within tuberculosis care.
    Int J Tuberc Lung Dis. 2017;21:149-153.
    PubMed     Text format     Abstract available


  241. PARENT SN, Ehrlich R, Baxter V, Kannemeyer N, et al
    Participatory theatre and tuberculosis: a feasibility study with South African health care workers.
    Int J Tuberc Lung Dis. 2017;21:140-148.
    PubMed     Text format     Abstract available


  242. STAGG HR, Lipman MC, McHugh TD, Jenkins HE, et al
    Isoniazid-resistant tuberculosis: a cause for concern?
    Int J Tuberc Lung Dis. 2017;21:129-139.
    PubMed     Text format     Abstract available


  243. USDIN M, Dedicoat M, Gajraj R, Harrison P, et al
    Latent tuberculous screening of recent migrants attending language classes: a cohort study and cost analysis.
    Int J Tuberc Lung Dis. 2017;21:175-180.
    PubMed     Text format     Abstract available


    January 2017
  244. RIEDER HL, Van Deun A
    Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:123-124.
    PubMed     Text format    


  245. REVES R, Benjamin R
    The cost of the failure to eliminate tuberculosis in the United States.
    Int J Tuberc Lung Dis. 2017;21:120.
    PubMed     Text format    


  246. KUMAR NP, Velayutham B, Nair D, Babu S, et al
    Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:93-99.
    PubMed     Text format     Abstract available


  247. DAVIS A, Terlikbayeva A, Aifah A, Hermosilla S, et al
    Risks for tuberculosis in Kazakhstan: implications for prevention.
    Int J Tuberc Lung Dis. 2017;21:86-92.
    PubMed     Text format     Abstract available


  248. SHAWENO D, Shaweno T, Trauer JM, Denholm JT, et al
    Heterogeneity of distribution of tuberculosis in Sheka Zone, Ethiopia: drivers and temporal trends.
    Int J Tuberc Lung Dis. 2017;21:79-85.
    PubMed     Text format     Abstract available


  249. KOURA KG, Trebucq A, Schwoebel V
    Do active case-finding projects increase the number of tuberculosis cases notified at national level?
    Int J Tuberc Lung Dis. 2017;21:73-78.
    PubMed     Text format     Abstract available


  250. RUDOLF F, Wagner AJ, Back FM, Gomes VF, et al
    Tuberculosis case finding and mortality prediction: added value of the clinical TBscore and biomarker suPAR.
    Int J Tuberc Lung Dis. 2017;21:67-72.
    PubMed     Text format     Abstract available


  251. RAGONNET R, Trauer JM, McBryde ES, Houben RM, et al
    Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact.
    Int J Tuberc Lung Dis. 2017;21:60-66.
    PubMed     Text format     Abstract available


  252. CHABALA C, Chongwe G, Jumbe-Marsden E, Somwe SW, et al
    Missed opportunities for screening child contacts of smear-positive tuberculosis in Zambia, a high-prevalence setting.
    Int J Tuberc Lung Dis. 2017;21:53-59.
    PubMed     Text format     Abstract available


  253. EGERE U, Togun T, Sillah A, Mendy F, et al
    Identifying children with tuberculosis among household contacts in The Gambia.
    Int J Tuberc Lung Dis. 2017;21:46-52.
    PubMed     Text format     Abstract available


  254. ZELDOW B, Kim S, McSherry G, Cotton MF, et al
    Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041.
    Int J Tuberc Lung Dis. 2017;21:38-45.
    PubMed     Text format     Abstract available


  255. JERENE D, Abebe W, Taye K, Suarez PG, et al
    Tuberculosis along the continuum of HIV care in a cohort of adolescents living with HIV in Ethiopia.
    Int J Tuberc Lung Dis. 2017;21:32-37.
    PubMed     Text format     Abstract available


  256. TUPASI T, Garfin AM, Mangan JM, Orillaza-Chi R, et al
    Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-up.
    Int J Tuberc Lung Dis. 2017;21:23-31.
    PubMed     Text format     Abstract available


  257. WELDEGEBREAL S, Mebrahtu T
    Anti-tuberculosis drug resistance in Ethiopia: systematic review.
    Int J Tuberc Lung Dis. 2017;21:18-22.
    PubMed     Text format     Abstract available


  258. BANU S, Rahman MT, Ahmed S, Khatun R, et al
    Multidrug-resistant tuberculosis in Bangladesh: results from a sentinel surveillance system.
    Int J Tuberc Lung Dis. 2017;21:12-17.
    PubMed     Text format     Abstract available


  259. NOURZAD S, Jenkins HE, Milstein M, Mitnick CD, et al
    Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:6-11.
    PubMed     Text format     Abstract available


  260. FURIN J, Diacon AH, Andries K
    Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.
    Int J Tuberc Lung Dis. 2017;21:4-5.
    PubMed     Text format    


    December 2016
  261. STURKENBOOM MG, Bolhuis MS, Akkerman OW, de Lange WC, et al
    Therapeutic drug monitoring of first-line anti-tuberculosis drugs comprises more than C2h measurements.
    Int J Tuberc Lung Dis. 2016;20:1695-1696.
    PubMed     Text format    


  262. VELAYUTHAM B, Nair D, Kannan T, Padmapriyadarsini C, et al
    Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1671-1676.
    PubMed     Text format     Abstract available


  263. SINGANAYAGAM A, Manalan K, Connell DW, Chalmers JD, et al
    Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1653-1660.
    PubMed     Text format     Abstract available


  264. EL AZBAOUI S, Sabri A, Ouraini S, Hassani A, et al
    Utility of the QuantiFERON-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
    Int J Tuberc Lung Dis. 2016;20:1639-1646.
    PubMed     Text format     Abstract available


  265. CONNERS E, Garfein RS, Rodwell TC, Udwadia ZF, et al
    Mobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, India.
    Int J Tuberc Lung Dis. 2016;20:1633-1638.
    PubMed     Text format     Abstract available


  266. ZELNICK JR, O'Donnell MR, Ahuja SD, Chua A, et al
    Health care provider perspectives on tuberculosis care for foreign-born populations in New York City.
    Int J Tuberc Lung Dis. 2016;20:1625-1632.
    PubMed     Text format     Abstract available


  267. BRIGHT-THOMAS RJ, Gondker AR, Morris J, Ormerod LP, et al
    Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period.
    Int J Tuberc Lung Dis. 2016;20:1621-1624.
    PubMed     Text format     Abstract available


  268. RENDELL NL, Batjargal N, Jadambaa N, Dobler CC, et al
    Risk of tuberculosis during pregnancy in Mongolia, a high incidence setting with low HIV prevalence.
    Int J Tuberc Lung Dis. 2016;20:1615-1620.
    PubMed     Text format     Abstract available


  269. MBATCHOU NGAHANE BH, Dahirou F, Tchieche C, Wandji A, et al
    Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.
    Int J Tuberc Lung Dis. 2016;20:1609-1614.
    PubMed     Text format     Abstract available


  270. SIROKA A, Law I, Macinko J, Floyd K, et al
    The effect of household poverty on tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1603-1608.
    PubMed     Text format     Abstract available


  271. MARGALIT I, Block C, Mor Z
    Seasonality of tuberculosis in Israel, 20012011.
    Int J Tuberc Lung Dis. 2016;20:1588-1593.
    PubMed     Text format     Abstract available


  272. JENSEN SG, Lillebaek T, Wilcke T, Pedersen MK, et al
    Impact of contact investigation and tuberculosis screening among high-risk groups in Denmark.
    Int J Tuberc Lung Dis. 2016;20:1580-1587.
    PubMed     Text format     Abstract available


  273. CASTRO KG
    Detection and treatment of persons with latent tuberculosis infection: first eliminate the policy-to-practice gap.
    Int J Tuberc Lung Dis. 2016;20:1565.
    PubMed     Text format    


  274. TALAVERA-PAULIN M, Garcia-Morales L, Ruiz-Sanchez BP, Caamal-Ley AD, et al
    Active tuberculosis patients have high levels of IgA anti-alpha-crystallin and isocitrate lyase proteins.
    Int J Tuberc Lung Dis. 2016;20:1681-1688.
    PubMed     Text format     Abstract available


  275. EL AZBAOUI S, Sabri A, Ouraini S, Hassani A, et al
    Utility of the QuantiFERON(R)-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
    Int J Tuberc Lung Dis. 2016;20:1639-1646.
    PubMed     Text format     Abstract available


  276. MBATCHOU NGAHANE BH, Dahirou F, Tchieche C, Wandji A, et al
    Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.
    Int J Tuberc Lung Dis. 2016;20:1609-1614.
    PubMed     Text format     Abstract available


  277. MARGALIT I, Block C, Mor Z
    Seasonality of tuberculosis in Israel, 2001-2011.
    Int J Tuberc Lung Dis. 2016;20:1588-1593.
    PubMed     Text format     Abstract available


  278. BRUGUERAS S, Orcau A, Millet JP, Espinosa L, et al
    Tuberculosis clinical units improve contact tracing.
    Int J Tuberc Lung Dis. 2016;20:1572-1579.
    PubMed     Text format     Abstract available


  279. O'DONNELL MR, Padayatchi N, Metcalfe JZ
    Elucidating the role of clofazimine for the treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:52-57.
    PubMed     Text format     Abstract available


  280. NUERMBERGER E
    Evolving strategies for dose optimization of linezolid for treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:48-51.
    PubMed     Text format     Abstract available


  281. STERLING TR
    Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:42-47.
    PubMed     Text format     Abstract available


  282. MURRAY S, Mendel C, Spigelman M
    TB Alliance regimen development for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:38-41.
    PubMed     Text format     Abstract available


  283. GUPTA R, Wells CD, Hittel N, Hafkin J, et al
    Delamanid in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:33-37.
    PubMed     Text format     Abstract available


  284. MILSTEIN M, Brzezinski A, Varaine F, Mitnick CD, et al
    (Re)moving the needle: prospects for all-oral treatment for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:18-23.
    PubMed     Text format     Abstract available


    November 2016
  285. DHOLAKIA Y, Mistry N
    Active tuberculosis case finding in a migrant slum community, Mumbai, India.
    Int J Tuberc Lung Dis. 2016;20:1562.
    PubMed     Text format    


  286. LEVIN A, Sklyuev S, Felker I, Tceymach E, et al
    Endobronchial valve treatment of destructive multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1539-1545.
    PubMed     Text format     Abstract available


  287. PINA RZ, Caleffi-Ferracioli KR, Campanerut-Sa PA, Ghiraldi-Lopez LD, et al
    Pyrazinamide susceptibility testing in Mycobacterium tuberculosis using the fast resazurin microtiter assay plate.
    Int J Tuberc Lung Dis. 2016;20:1535-1538.
    PubMed     Text format     Abstract available


  288. ALIPANAH N, Cattamanchi A, Menzies R, Hopewell PC, et al
    Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:1522-1528.
    PubMed     Text format     Abstract available


  289. KIM CH, Lim JK, Lee DH, Yoo SS, et al
    Outcomes of standard and tailored anti-tuberculosis regimens in patients with tuberculous pleural effusion.
    Int J Tuberc Lung Dis. 2016;20:1516-1521.
    PubMed     Text format     Abstract available


  290. IGLECIAS LM, Puga MA, Pompilio MA, Teles SA, et al
    Epidemiological study of hepatitis B virus among prisoners with active tuberculosis in Central Brazil.
    Int J Tuberc Lung Dis. 2016;20:1509-1515.
    PubMed     Text format     Abstract available


  291. IZUMI K, Kawatsu L, Ohkado A, Uchimura K, et al
    Evaluating the impact of health resource reconstruction on improving spatial accessibility of tuberculosis care.
    Int J Tuberc Lung Dis. 2016;20:1501-1508.
    PubMed     Text format     Abstract available


  292. LOPEZ AL, Aldaba JG, Ama CG, Sylim PG, et al
    Surveillance for tuberculosis in a rural community in The Philippines.
    Int J Tuberc Lung Dis. 2016;20:1495-1500.
    PubMed     Text format     Abstract available


  293. NOESKE J, Nana Yakam A, Abena Foe JL
    Epidemiology of tuberculosis in Cameroon as mirrored in notification data, 2006-2014.
    Int J Tuberc Lung Dis. 2016;20:1489-1494.
    PubMed     Text format     Abstract available


  294. DAFTARY A, Padayatchi N
    Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study.
    Int J Tuberc Lung Dis. 2016;20:1483-1488.
    PubMed     Text format     Abstract available


  295. MIBEI DJ, Kiarie JW, Wairia A, Kamene M, et al
    Treatment outcomes of drug-resistant tuberculosis patients in Kenya.
    Int J Tuberc Lung Dis. 2016;20:1477-1482.
    PubMed     Text format     Abstract available


  296. GARCIA-PRATS AJ, du Plessis L, Draper HR, Burger A, et al
    Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in children.
    Int J Tuberc Lung Dis. 2016;20:1469-1476.
    PubMed     Text format     Abstract available


  297. CHAYA S, Dangor Z, Solomon F, Nzenze SA, et al
    Incidence of tuberculosis meningitis in a high HIV prevalence setting: time-series analysis from 2006 to 2011.
    Int J Tuberc Lung Dis. 2016;20:1457-1462.
    PubMed     Text format     Abstract available


  298. TURKOVA A, Chappell E, Chalermpantmetagul S, Negra MD, et al
    Tuberculosis in HIV-infected children in Europe, Thailand and Brazil: paediatric TB-HIV EuroCoord study.
    Int J Tuberc Lung Dis. 2016;20:1448-1456.
    PubMed     Text format     Abstract available


  299. JAGANATH D, Lamichhane G, Shah M
    Carbapenems against Mycobacterium tuberculosis: a review of the evidence.
    Int J Tuberc Lung Dis. 2016;20:1436-1447.
    PubMed     Text format     Abstract available


  300. UPLEKAR M
    Public-private mix for tuberculosis care and prevention. What progress? What prospects?
    Int J Tuberc Lung Dis. 2016;20:1424-1429.
    PubMed     Text format     Abstract available


    October 2016
  301. NUNN A, Tweed C
    Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap.
    Int J Tuberc Lung Dis. 2016;20:1418-1419.
    PubMed     Text format    


  302. KARAKAS A, Turhan V, Esquinas AM
    Reasons for high mortality rates in patients with pulmonary tuberculosis needing mechanical ventilation.
    Int J Tuberc Lung Dis. 2016;20:1416-1417.
    PubMed     Text format    


  303. FRIEDEN TR
    Positive bacteriological results among contacts of patients with active tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1416.
    PubMed     Text format    


  304. NAIDOO P, Dunbar R, du Toit E, van Niekerk M, et al
    Comparing laboratory costs of smear/culture and Xpert(R) MTB/RIF-based tuberculosis diagnostic algorithms.
    Int J Tuberc Lung Dis. 2016;20:1377-1385.
    PubMed     Text format     Abstract available


  305. ZHAO Q, Xiao X, Lu W, Qiu LX, et al
    Screening diabetes in tuberculosis patients in eastern rural China: a community-based cross-sectional study.
    Int J Tuberc Lung Dis. 2016;20:1370-1376.
    PubMed     Text format     Abstract available


  306. WATTANAPOKAYAKIT S, Mushiroda T, Yanai H, Wichukchinda N, et al
    NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients.
    Int J Tuberc Lung Dis. 2016;20:1364-1369.
    PubMed     Text format     Abstract available


  307. THIEL BA, Bark CM, Nakibali JG, van der Kuyp F, et al
    Reader variability and validation of the Timika X-ray score during treatment of pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1358-1363.
    PubMed     Text format     Abstract available


  308. PARCHURE R, Kulkarni V, Gangakhedkar R, Swaminathan S, et al
    Treatment outcomes of daily anti-tuberculosis treatment in HIV-infected patients seeking care at a private clinic in India.
    Int J Tuberc Lung Dis. 2016;20:1348-1353.
    PubMed     Text format     Abstract available


  309. TOLLEFSON D, Ngari F, Mwakala M, Gethi D, et al
    Under-reporting of sputum smear-positive tuberculosis cases in Kenya.
    Int J Tuberc Lung Dis. 2016;20:1334-1341.
    PubMed     Text format     Abstract available


  310. SENKORO M, Kumar AM, Chinnakali P, Mfinanga SG, et al
    Population impact of factors associated with prevalent pulmonary tuberculosis in Tanzania.
    Int J Tuberc Lung Dis. 2016;20:1326-1333.
    PubMed     Text format     Abstract available


  311. ENANE LA, Lowenthal ED, Arscott-Mills T, Matlhare M, et al
    Loss to follow-up among adolescents with tuberculosis in Gaborone, Botswana.
    Int J Tuberc Lung Dis. 2016;20:1320-1325.
    PubMed     Text format     Abstract available


  312. STILLSON CH, Okatch H, Frasso R, Mazhani L, et al
    'That's when I struggle' ... Exploring challenges faced by care givers of children with tuberculosis in Botswana.
    Int J Tuberc Lung Dis. 2016;20:1314-1319.
    PubMed     Text format     Abstract available


  313. SULIS G, Gnanou S, Roggi A, Konseimbo A, et al
    Active tuberculosis case finding among pregnant women: a pilot project in Burkina Faso.
    Int J Tuberc Lung Dis. 2016;20:1306-1308.
    PubMed     Text format     Abstract available


  314. MUNANG ML, Browne C, Evans JT, Smith EG, et al
    Programmatic utility of tuberculosis cluster investigation using a social network approach in Birmingham, United Kingdom.
    Int J Tuberc Lung Dis. 2016;20:1300-1305.
    PubMed     Text format     Abstract available


  315. TEBRUEGGE M, Buonsenso D, Brinkmann F, Noguera-Julian A, et al
    European shortage of purified protein derivative and its impact on tuberculosis screening practices.
    Int J Tuberc Lung Dis. 2016;20:1293-1299.
    PubMed     Text format     Abstract available


  316. TREBUCQ A, Schwoebel V
    Numbers of tuberculosis cases: dreams and reality.
    Int J Tuberc Lung Dis. 2016;20:1288-1292.
    PubMed     Text format     Abstract available


  317. LONG R, Lau A
    How R G Ferguson's groundbreaking studies influenced our understanding of tuberculosis reinfection. Where to next?
    Int J Tuberc Lung Dis. 2016;20:1285-1287.
    PubMed     Text format    


  318. LONNROTH K, Shah NS, Lange C
    State-of-the-art series on tuberculosis and migration.
    Int J Tuberc Lung Dis. 2016;20:1280-1281.
    PubMed     Text format    


    September 2016
  319. EILERTSON B, Maruri F, Blackman A, Herrera M, et al
    Reversion of phenotypic fluoroquinolone resistance in Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1276-7.
    PubMed     Text format    


  320. OTTO-KNAPP R, Vesenbeckh S, Schonfeld N, Bettermann G, et al
    Isoniazid minimal inhibitory concentrations of tuberculosis strains with katG mutation.
    Int J Tuberc Lung Dis. 2016;20:1275-6.
    PubMed     Text format    


  321. HEMANTH KUMAR AK, Kannan T, Chandrasekaran V, Sudha V, et al
    Pharmacokinetics of thrice-weekly rifampicin, isoniazid and pyrazinamide in adult tuberculosis patients in India.
    Int J Tuberc Lung Dis. 2016;20:1236-41.
    PubMed     Text format     Abstract available


  322. PANDE T, Cohen C, Pai M, Ahmad Khan F, et al
    Computer-aided detection of pulmonary tuberculosis on digital chest radiographs: a systematic review.
    Int J Tuberc Lung Dis. 2016;20:1226-30.
    PubMed     Text format     Abstract available


  323. NUNES C, Taylor BM
    Modelling the time to detection of urban tuberculosis in two big cities in Portugal: a spatial survival analysis.
    Int J Tuberc Lung Dis. 2016;20:1219-25.
    PubMed     Text format     Abstract available


  324. MANGAN JM, Tupasi TE, Garfin AM, Lofranco V, et al
    Multidrug-resistant tuberculosis patients lost to follow-up: self-reported readiness to restart treatment.
    Int J Tuberc Lung Dis. 2016;20:1205-11.
    PubMed     Text format     Abstract available


  325. KWEDI NOLNA S, Kammogne ID, Ndzinga R, Afanda B, et al
    Community knowledge, attitudes and practices in relation to tuberculosis in Cameroon.
    Int J Tuberc Lung Dis. 2016;20:1199-204.
    PubMed     Text format     Abstract available


  326. DEMEMEW ZG, Habte D, Melese M, Hamusse SD, et al
    Trends in tuberculosis case notification and treatment outcomes after interventions in 10 zones of Ethiopia.
    Int J Tuberc Lung Dis. 2016;20:1192-8.
    PubMed     Text format     Abstract available


  327. KAPLAN R, Caldwell J, Hermans S, Adriaanse S, et al
    An integrated community TB-HIV adherence model provides an alternative to DOT for tuberculosis patients in Cape Town.
    Int J Tuberc Lung Dis. 2016;20:1185-91.
    PubMed     Text format     Abstract available


  328. JENKS JD, Kumarasamy N, Ezhilarasi C, Poongulali S, et al
    Improved tuberculosis outcomes with daily vs. intermittent rifabutin in HIV-TB coinfected patients in India.
    Int J Tuberc Lung Dis. 2016;20:1181-4.
    PubMed     Text format     Abstract available


  329. YHI JY, Park DW, Min JH, Park YK, et al
    Measurement of levels of fractional exhaled nitric oxide in patients with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1174-80.
    PubMed     Text format     Abstract available


  330. BHATRAJU P, Patrawalla P, Trieu L, Ahuja SD, et al
    Errors in isolation of patients with infectious tuberculosis at a public teaching hospital in New York.
    Int J Tuberc Lung Dis. 2016;20:1168-73.
    PubMed     Text format     Abstract available


  331. RAO SA, Kadhiravan T, Swaminathan RP, Mahadevan S, et al
    Occupational exposure and tuberculosis among medical residents in a high-burden setting: an open-cohort study.
    Int J Tuberc Lung Dis. 2016;20:1162-7.
    PubMed     Text format     Abstract available


  332. TAYLOR JG, Yates TA, Mthethwa M, Tanser F, et al
    Measuring ventilation and modelling M. tuberculosis transmission in indoor congregate settings, rural KwaZulu-Natal.
    Int J Tuberc Lung Dis. 2016;20:1155-61.
    PubMed     Text format     Abstract available


  333. SUTHAR AB, Zachariah R, Harries AD
    Ending tuberculosis by 2030: can we do it?
    Int J Tuberc Lung Dis. 2016;20:1148-54.
    PubMed     Text format     Abstract available


  334. CHIANG CY, Van Deun A, Rieder HL
    Gatifloxacin for short, effective treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1143-7.
    PubMed     Text format     Abstract available


  335. TWEED C, Nunn A
    Occupational exposure to tuberculosis in endemic areas: room for improvement.
    Int J Tuberc Lung Dis. 2016;20:1139.
    PubMed     Text format    


  336. SCARDIGLI A, Caminero JA
    Simple and practical measures to reduce tuberculosis transmission in public buildings.
    Int J Tuberc Lung Dis. 2016;20:1137-8.
    PubMed     Text format    


    August 2016
  337. DAUM LT, Fourie PB, Peters RP, Rodriguez JD, et al
    Xpert((R)) MTB/RIF detection of Mycobacterium tuberculosis from sputum collected in molecular transport medium.
    Int J Tuberc Lung Dis. 2016;20:1118-24.
    PubMed     Text format     Abstract available


  338. ATWEBEMBEIRE J, Orikiriza P, Bonnet M, Atwine D, et al
    Xpert((R)) MTB/RIF for detection of Mycobacterium tuberculosis from frozen string and induced sputum sediments.
    Int J Tuberc Lung Dis. 2016;20:1113-7.
    PubMed     Text format     Abstract available


  339. BOLLELA VR, Namburete EI, Feliciano CS, Macheque D, et al
    Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1099-104.
    PubMed     Text format     Abstract available


  340. MONTGOMERY CM
    Adaptive trials for tuberculosis: early reflections on theory and practice.
    Int J Tuberc Lung Dis. 2016;20:1091-8.
    PubMed     Text format     Abstract available


  341. STRINGER B, Lowton K, Tillashaikhov M, Parpieva N, et al
    'They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan.
    Int J Tuberc Lung Dis. 2016;20:1084-90.
    PubMed     Text format     Abstract available


  342. TRIASIH R, Padmawati RS, Duke T, Robertson C, et al
    A mixed-methods evaluation of adherence to preventive treatment among child tuberculosis contacts in Indonesia.
    Int J Tuberc Lung Dis. 2016;20:1078-83.
    PubMed     Text format     Abstract available


  343. MARITZ ER, Montepiedra G, Liu L, Mitchell CD, et al
    Source case identification in HIV-exposed infants and tuberculosis diagnosis in an isoniazid prevention study.
    Int J Tuberc Lung Dis. 2016;20:1060-4.
    PubMed     Text format     Abstract available


  344. ADJOBIMEY M, Masserey E, Adjonou C, Gbenagnon G, et al
    Implementation of isoniazid preventive therapy in children aged under 5 years exposed to tuberculosis in Benin.
    Int J Tuberc Lung Dis. 2016;20:1055-9.
    PubMed     Text format     Abstract available


  345. FLICK RJ, Kim MH, Simon K, Munthali A, et al
    Burden of disease and risk factors for death among children treated for tuberculosis in Malawi.
    Int J Tuberc Lung Dis. 2016;20:1046-54.
    PubMed     Text format     Abstract available


  346. BRENNAN AT, Bonawitz R, Schnippel K, Berhanu R, et al
    Incident tuberculosis in HIV-positive children, adolescents and adults on antiretroviral therapy in South Africa.
    Int J Tuberc Lung Dis. 2016;20:1040-5.
    PubMed     Text format     Abstract available


  347. HENOSTROZA G, Harris JB, Chitambi R, Siyambango M, et al
    High prevalence of tuberculosis in newly enrolled HIV patients in Zambia: need for enhanced screening approach.
    Int J Tuberc Lung Dis. 2016;20:1033-9.
    PubMed     Text format     Abstract available


  348. SOUSA P, Oliveira A, Gomes M, Gaio AR, et al
    Longitudinal clustering of tuberculosis incidence and predictors for the time profiles: the impact of HIV.
    Int J Tuberc Lung Dis. 2016;20:1027-32.
    PubMed     Text format     Abstract available


  349. SUBRAMANI R, Gomathy S, Lakshmi M, Swaminathan S, et al
    Trend in the incidence of smear-positive tuberculosis in a district in South India after DOTS implementation.
    Int J Tuberc Lung Dis. 2016;20:1022-6.
    PubMed     Text format     Abstract available


  350. SENKORO M, Mfinanga S, Egwaga S, Mtandu R, et al
    Prevalence of pulmonary tuberculosis in adult population of Tanzania: a national survey, 2012.
    Int J Tuberc Lung Dis. 2016;20:1014-21.
    PubMed     Text format     Abstract available


  351. SABIITI W, Mtafya B, Kuchaka D, Azam K, et al
    Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings.
    Int J Tuberc Lung Dis. 2016;20:1004-9.
    PubMed     Text format     Abstract available


  352. ANDRE E, Isaacs C, Affolabi D, Alagna R, et al
    Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination.
    Int J Tuberc Lung Dis. 2016;20:999-1003.
    PubMed     Text format     Abstract available


  353. HESSELING AC, Rabie H
    Tuberculosis and HIV remain major causes of death in African children.
    Int J Tuberc Lung Dis. 2016;20:996-7.
    PubMed     Text format    


    July 2016
  354. MAJUMDER A, Carroll B, Bhana S, Tefu D, et al
    Screening for active tuberculosis in a diabetes mellitus clinic in Soweto, South Africa.
    Int J Tuberc Lung Dis. 2016;20:992-3.
    PubMed     Text format    


  355. GERONA R, Wen A, Koss C, Bacchetti P, et al
    A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs.
    Int J Tuberc Lung Dis. 2016;20:991-2.
    PubMed     Text format    


  356. CASTRO JL
    In reply: The language of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:989-90.
    PubMed     Text format    


  357. DESHMUKH R
    Targeting zero tuberculosis deaths among people living with HIV: a call for action.
    Int J Tuberc Lung Dis. 2016;20:988.
    PubMed     Text format    


  358. LESSEM E, Frick M
    Ensuring availability of the best tuberculosis treatment options in the Philippines.
    Int J Tuberc Lung Dis. 2016;20:988-9.
    PubMed     Text format    


  359. OH KH, Kim HJ, Kim MH
    Non-communicable diseases and risk of tuberculosis in Korea.
    Int J Tuberc Lung Dis. 2016;20:973-7.
    PubMed     Text format     Abstract available


  360. YIN XM, Wu LJ, Zheng L, Mao XR, et al
    Quantification of colony-forming units for M. tuberculosis complex using gyrB-based real-time PCR assay.
    Int J Tuberc Lung Dis. 2016;20:967-72.
    PubMed     Text format     Abstract available


  361. SHIN SS, Chang AH, Ghosh JK, Dube MP, et al
    Isoniazid therapy for Mycobacterium tuberculosis infection in HIV clinics, Los Angeles, California.
    Int J Tuberc Lung Dis. 2016;20:961-6.
    PubMed     Text format     Abstract available


  362. MAZE MJ, Paynter J, Chiu W, Hu R, et al
    Therapeutic drug monitoring of isoniazid and rifampicin during anti-tuberculosis treatment in Auckland, New Zealand.
    Int J Tuberc Lung Dis. 2016;20:955-60.
    PubMed     Text format     Abstract available


  363. CHOI H, Chung H, Muntaner C, Lee M, et al
    The impact of social conditions on patient adherence to pulmonary tuberculosis treatment.
    Int J Tuberc Lung Dis. 2016;20:948-54.
    PubMed     Text format     Abstract available


  364. CASTRO KG, Marks SM, Chen MP, Hill AN, et al
    Estimating tuberculosis cases and their economic costs averted in the United States over the past two decades.
    Int J Tuberc Lung Dis. 2016;20:926-33.
    PubMed     Text format     Abstract available


  365. IBARZ-PAVON AB, Papaventsis D, Kalkouni R, Metaxas G, et al
    Pilot study of the completeness of notification of adult tuberculosis in Athens, Greece.
    Int J Tuberc Lung Dis. 2016;20:920-5.
    PubMed     Text format     Abstract available


  366. PAVLINAC PB, Lokken EM, Walson JL, Richardson BA, et al
    Mycobacterium tuberculosis bacteremia in adults and children: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:895-902.
    PubMed     Text format     Abstract available


  367. BARES R, Khalid N, Daniel H, Dittmann H, et al
    Hypothyroidism during second-line treatment of multidrug-resistant tuberculosis: a prospective study.
    Int J Tuberc Lung Dis. 2016;20:876-81.
    PubMed     Text format     Abstract available


  368. STAGG HR, Hatherell HA, Lipman MC, Harris RJ, et al
    Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap.
    Int J Tuberc Lung Dis. 2016;20:866-9.
    PubMed     Text format     Abstract available


  369. DEAN AS, Zignol M, Lumb R, Lalor M, et al
    Sputum smear microscopy result: a predictor for drug-resistant tuberculosis?
    Int J Tuberc Lung Dis. 2016;20:864-5.
    PubMed     Text format     Abstract available


  370. KOETHE JR, von Reyn CF
    Protein-calorie malnutrition, macronutrient supplements, and tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:857-63.
    PubMed     Text format     Abstract available


    June 2016
  371. BALCELLS ME, Huilcaman M, Pena C, Castillo C, et al
    M. tuberculosis DNA detection in nasopharyngeal mucosa can precede tuberculosis development in contacts.
    Int J Tuberc Lung Dis. 2016;20:848-52.
    PubMed     Text format     Abstract available


  372. MAVE V, Chandanwale A, Kinikar A, Khadse S, et al
    Isoniazid hair concentrations in children with tuberculosis: a proof of concept study.
    Int J Tuberc Lung Dis. 2016;20:844-7.
    PubMed     Text format     Abstract available


  373. SINGH M, Sethi GR, Mantan M, Khanna A, et al
    Xpert((R)) MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children.
    Int J Tuberc Lung Dis. 2016;20:839-43.
    PubMed     Text format     Abstract available


  374. JINDANI A, Borgulya G, de Patino IW, Gonzales T, et al
    A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:832-8.
    PubMed     Text format     Abstract available


  375. HOLLAND DP, Hamilton CD, Stout JE
    Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis.
    Int J Tuberc Lung Dis. 2016;20:827-31.
    PubMed     Text format     Abstract available


  376. MOTA L, Al-Efraij K, Campbell JR, Cook VJ, et al
    Therapeutic drug monitoring in anti-tuberculosis treatment: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:819-26.
    PubMed     Text format     Abstract available


  377. CHEN R, Wang J, Tang SW, Zhang Y, et al
    CYP7A1, BAAT and UGT1A1 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.
    Int J Tuberc Lung Dis. 2016;20:812-8.
    PubMed     Text format     Abstract available


  378. DHATWALIA SK, Yadav R, Behera D, Rudramurthy SM, et al
    Distribution and association of Mycobacterium tuberculosis CAS lineage with multidrug resistance in North India.
    Int J Tuberc Lung Dis. 2016;20:806-11.
    PubMed     Text format     Abstract available


  379. LEE SS, Lee CM, Kim TH, Kim JJ, et al
    Frequency and risk factors of drug-induced liver injury during treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:800-5.
    PubMed     Text format     Abstract available


  380. SANDER MS, Vuchas CY, Numfor HN, Nsimen AN, et al
    Sputum bacterial load predicts multidrug-resistant tuberculosis in retreatment patients: a case-control study.
    Int J Tuberc Lung Dis. 2016;20:793-9.
    PubMed     Text format     Abstract available


  381. JENSENIUS M, Winje BA, Blomberg B, Mengshoel AT, et al
    Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014.
    Int J Tuberc Lung Dis. 2016;20:786-92.
    PubMed     Text format     Abstract available


  382. MACPHERSON P, Squire SB, Cleary P, Davies S, et al
    Equitable tuberculosis care in the North West of England: analysis of tuberculosis cohort review data.
    Int J Tuberc Lung Dis. 2016;20:778-85.
    PubMed     Text format     Abstract available


  383. CARAFFA E, Schepisi MS, Gualano G, Parracino MP, et al
    The diabetes-tuberculosis co-epidemic: the role of international migration.
    Int J Tuberc Lung Dis. 2016;20:771-7.
    PubMed     Text format     Abstract available


  384. CAMPBELL JR, Krot J, Marra F
    Latent tuberculosis diagnostic tests to predict longitudinal tuberculosis during dialysis: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:764-70.
    PubMed     Text format     Abstract available


  385. EVERATT R, Kuzmickiene I, Davidaviciene E, Cicenas S, et al
    Incidence of lung cancer among patients with tuberculosis: a nationwide cohort study in Lithuania.
    Int J Tuberc Lung Dis. 2016;20:757-63.
    PubMed     Text format     Abstract available


  386. LEUNG CC
    Does tuberculosis increase the risk of lung cancer?
    Int J Tuberc Lung Dis. 2016;20:712.
    PubMed     Text format    


    May 2016
  387. BRANAGAN P, Moran B, Fitzgibbon M, Reid V, et al
    Inoculation site leprosy in a tattoo as a paradoxical reaction following tuberculosis treatment.
    Int J Tuberc Lung Dis. 2016;20:706-8.
    PubMed     Text format     Abstract available


  388. ARYANPUR M, Masjedi MR, Hosseini M, Mortaz E, et al
    Cigarette smoking in patients newly diagnosed with pulmonary tuberculosis in Iran.
    Int J Tuberc Lung Dis. 2016;20:679-84.
    PubMed     Text format     Abstract available


  389. YELLAPPA V, Battaglioli T, Gurum SK, Narayanan D, et al
    Private practitioners' contributions to the Revised National Tuberculosis Control Programme in a South Indian district.
    Int J Tuberc Lung Dis. 2016;20:659-65.
    PubMed     Text format     Abstract available


  390. GLOBAN M, Lavender C, Leslie D, Brown L, et al
    Molecular epidemiology of tuberculosis in Victoria, Australia, reveals low level of transmission.
    Int J Tuberc Lung Dis. 2016;20:652-8.
    PubMed     Text format     Abstract available


  391. GURBANOVA E, Mehdiyev R, Blondal K, Altraja A, et al
    Predictors of cure in rifampicin-resistant tuberculosis in prison settings with low loss to follow-up.
    Int J Tuberc Lung Dis. 2016;20:645-51.
    PubMed     Text format     Abstract available


  392. SEIFERT M, Ajbani K, Georghiou SB, Catanzaro D, et al
    A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:631-7.
    PubMed     Text format     Abstract available


  393. PINTO M, Steffen RE, Cobelens F, van den Hof S, et al
    Cost-effectiveness of the Xpert((R)) MTB/RIF assay for tuberculosis diagnosis in Brazil.
    Int J Tuberc Lung Dis. 2016;20:611-8.
    PubMed     Text format     Abstract available


  394. QUISPE R, Valle GA, Huapaya JA, Novoa I, et al
    Manual MGIT system for the detection of Mycobacterium tuberculosis: insights from a high TB burden setting.
    Int J Tuberc Lung Dis. 2016;20:605-10.
    PubMed     Text format     Abstract available


  395. JOHNSON MG, Stout JE, Benator DA, Whitworth WC, et al
    Medium matters: modeling the impact of solid medium performance on tuberculosis trial sample size requirements.
    Int J Tuberc Lung Dis. 2016;20:600-4.
    PubMed     Text format     Abstract available


  396. NAKAGGWA P, Odeke R, Kirenga BJ, Bloss E, et al
    Incomplete sputum smear microscopy monitoring among smear-positive tuberculosis patients in Uganda.
    Int J Tuberc Lung Dis. 2016;20:594-9.
    PubMed     Text format     Abstract available


  397. CHUCK C, Robinson E, Macaraig M, Alexander M, et al
    Enhancing management of tuberculosis treatment with video directly observed therapy in New York City.
    Int J Tuberc Lung Dis. 2016;20:588-93.
    PubMed     Text format     Abstract available


  398. NAGAVCI BL, de Gelder R, Martikainen P, Deboosere P, et al
    Inequalities in tuberculosis mortality: long-term trends in 11 European countries.
    Int J Tuberc Lung Dis. 2016;20:574-81.
    PubMed     Text format     Abstract available


  399. CHAULK CP, Belknap R
    A public heath 'selfie' for treating tuberculosis?
    Int J Tuberc Lung Dis. 2016;20:571.
    PubMed     Text format    


  400. VAN RIE A, Taylor R
    Can we translate findings on inequality in tuberculosis mortality into policy?
    Int J Tuberc Lung Dis. 2016;20:569-70.
    PubMed     Text format    


  401. NICOLINI A, Perazzo A, Gatto P, Piroddi IM, et al
    A rare adverse reaction to ethambutol: drug-induced haemolytic anaemia.
    Int J Tuberc Lung Dis. 2016;20:704-5.
    PubMed     Text format     Abstract available


  402. MUKHERJEE A, Velpandian T, Singla M, Kanhiya K, et al
    Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
    Int J Tuberc Lung Dis. 2016;20:666-72.
    PubMed     Text format     Abstract available


  403. RUAN YZ, Li RZ, Wang XX, Wang LX, et al
    The affordability for patients of a new universal MDR-TB coverage model in China.
    Int J Tuberc Lung Dis. 2016;20:638-44.
    PubMed     Text format     Abstract available


  404. MODI M, Sharma K, Sharma M, Sharma A, et al
    Multitargeted loop-mediated isothermal amplification for rapid diagnosis of tuberculous meningitis.
    Int J Tuberc Lung Dis. 2016;20:625-30.
    PubMed     Text format     Abstract available


  405. MOK Y, Tan TY, Tay TR, Wong HS, et al
    Do we need transbronchial lung biopsy if we have bronchoalveolar lavage Xpert(R) MTB/RIF?
    Int J Tuberc Lung Dis. 2016;20:619-24.
    PubMed     Text format     Abstract available


    April 2016
  406. BRONNER MURRISON L, Ananthakrishnan R, Swaminathan A, Auguesteen S, et al
    How do patients access the private sector in Chennai, India? An evaluation of delays in tuberculosis diagnosis.
    Int J Tuberc Lung Dis. 2016;20:544-51.
    PubMed     Text format     Abstract available


  407. MCDOWELL A, Pai M
    Treatment as diagnosis and diagnosis as treatment: empirical management of presumptive tuberculosis in India.
    Int J Tuberc Lung Dis. 2016;20:536-43.
    PubMed     Text format     Abstract available


  408. CALDERON HERNAIZ R, Ruiz Giardin JM, Cabello Clotet N, Canora Lebrato J, et al
    Tuberculosis and immigration in an area of southwest Madrid.
    Int J Tuberc Lung Dis. 2016;20:530-5.
    PubMed     Text format     Abstract available


  409. KIM S, Kim H, Kim WJ, Lee SJ, et al
    Mortality and predictors in pulmonary tuberculosis with respiratory failure requiring mechanical ventilation.
    Int J Tuberc Lung Dis. 2016;20:524-9.
    PubMed     Text format     Abstract available


  410. DALE K, Tay E, Trevan P, Denholm JT, et al
    Mortality among tuberculosis cases in Victoria, 2002-2013: case fatality and factors associated with death.
    Int J Tuberc Lung Dis. 2016;20:515-23.
    PubMed     Text format     Abstract available


  411. KANAMORI H, Hatakeyama T, Uchiyama B, Weber DJ, et al
    Clinical and molecular epidemiological features of tuberculosis after the 2011 Japan earthquake and tsunami.
    Int J Tuberc Lung Dis. 2016;20:505-14.
    PubMed     Text format     Abstract available


  412. SWAMINATHAN A, du Cros P, Seddon JA, Quinnell S, et al
    Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications.
    Int J Tuberc Lung Dis. 2016;20:474-8.
    PubMed     Text format     Abstract available


  413. HUANG ZK, Luo Q, Qing C, Deng YT, et al
    Evaluation of the direct nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:468-73.
    PubMed     Text format     Abstract available


  414. LI H, Zhou LP, Luo J, Yu JP, et al
    Rapid colorimetric pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:462-7.
    PubMed     Text format     Abstract available


  415. ZHENG LH, Jia HY, Liu XJ, Sun HS, et al
    Modified cytospin slide microscopy method for rapid diagnosis of smear-negative pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:456-61.
    PubMed     Text format     Abstract available


  416. TAHSEEN S, Qadeer E, Khanzada FM, Rizvi AH, et al
    Use of Xpert((R)) MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in Pakistan.
    Int J Tuberc Lung Dis. 2016;20:448-55.
    PubMed     Text format     Abstract available


  417. MARKS SM, Hirsch-Moverman Y, Salcedo K, Graviss EA, et al
    Characteristics and costs of multidrug-resistant tuberculosis in-patient care in the United States, 2005-2007.
    Int J Tuberc Lung Dis. 2016;20:435-41.
    PubMed     Text format     Abstract available


  418. O'DONNELL MR, Daftary A, Frick M, Hirsch-Moverman Y, et al
    Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV.
    Int J Tuberc Lung Dis. 2016;20:430-4.
    PubMed     Text format     Abstract available


  419. SOTGIU G, Migliori GB
    TB-related mortality: a re-emerging problem in high-income countries?
    Int J Tuberc Lung Dis. 2016;20:428.
    PubMed     Text format    


  420. BILLO NE
    Costs for TB and MDR-TB: time to convene a WHO Emergency Committee on TB?
    Int J Tuberc Lung Dis. 2016;20:427.
    PubMed     Text format    


  421. BANDA H, Robinson R, Thomson R, Squire SB, et al
    The 'Practical Approach to Lung Health' in sub-Saharan Africa: a systematic review.
    Int J Tuberc Lung Dis. 2016;20:552-9.
    PubMed     Text format     Abstract available


  422. YU J, Wang ZJ, Chen LH, Li HH, et al
    Diagnostic accuracy of interferon-gamma release assays for tuberculous meningitis: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:494-9.
    PubMed     Text format     Abstract available


  423. WANG F, Hou HY, Wu SJ, Zhu Q, et al
    Using the TBAg/PHA ratio in the T-SPOT((R)).TB assay to distinguish TB disease from LTBI in an endemic area.
    Int J Tuberc Lung Dis. 2016;20:487-93.
    PubMed     Text format     Abstract available


  424. SILVA AP, Hill P, Belo MT, Rabelo SG, et al
    Non-completion of latent tuberculous infection treatment among children in Rio de Janeiro State, Brazil.
    Int J Tuberc Lung Dis. 2016;20:479-86.
    PubMed     Text format     Abstract available


  425. KELLY AM, Smith B, Luo Z, Given B, et al
    Discordance between patient and clinician reports of adverse reactions to MDR-TB treatment.
    Int J Tuberc Lung Dis. 2016;20:442-7.
    PubMed     Text format     Abstract available


    March 2016
  426. SHIN SS, Modongo C, Zetola NM
    The impact of mixed infections on the interpretation of molecular epidemiology studies of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:423-4.
    PubMed     Text format    


  427. SARIN P, Duffy J, Mughal Z, Hedayat E, et al
    Vitamin D and tuberculosis: review and association in three rural provinces of Afghanistan.
    Int J Tuberc Lung Dis. 2016;20:383-8.
    PubMed     Text format     Abstract available


  428. LO HY, Yang SL, Lin HH, Bai KJ, et al
    Does enhanced diabetes management reduce the risk and improve the outcome of tuberculosis?
    Int J Tuberc Lung Dis. 2016;20:376-82.
    PubMed     Text format     Abstract available


  429. PARR JB, Rich ML, Keshavjee S, Franke MF, et al
    Presumptive treatment of multidrug-resistant tuberculosis in household contacts.
    Int J Tuberc Lung Dis. 2016;20:370-5.
    PubMed     Text format     Abstract available


  430. QIN F, Barry PM, Pascopella L
    Factors associated with extended treatment among tuberculosis patients at risk of relapse in California.
    Int J Tuberc Lung Dis. 2016;20:363-9.
    PubMed     Text format     Abstract available


  431. PAULINO J, Martins A, Machado M, Gomes M, et al
    Tuberculosis in native- and foreign-born populations in Portugal.
    Int J Tuberc Lung Dis. 2016;20:357-62.
    PubMed     Text format     Abstract available


  432. SMITH A, Burger R, Claassens M, Ayles H, et al
    Health care workers' gender bias in testing could contribute to missed tuberculosis among women in South Africa.
    Int J Tuberc Lung Dis. 2016;20:350-6.
    PubMed     Text format     Abstract available


  433. KHAN PY, Glynn JR, Fielding KL, Mzembe T, et al
    Risk factors for Mycobacterium tuberculosis infection in 2-4 year olds in a rural HIV-prevalent setting.
    Int J Tuberc Lung Dis. 2016;20:342-9.
    PubMed     Text format     Abstract available


  434. YU X, Ma YF, Jiang GL, Chen ST, et al
    Sensititre(R) MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates.
    Int J Tuberc Lung Dis. 2016;20:329-34.
    PubMed     Text format     Abstract available


  435. ZHANG T, Lv CF, Wang J, Zheng WB, et al
    Direct tuberculosis drug susceptibility testing: time-saving and cost-effective in detecting MDR-TB.
    Int J Tuberc Lung Dis. 2016;20:323-8.
    PubMed     Text format     Abstract available


  436. HO J, Nguyen PT, Nguyen TA, Tran HK, et al
    The role of macroscopic sputum quality assessments to optimise sputum testing for tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:319-22.
    PubMed     Text format     Abstract available


  437. HALIM KS, Islam MZ, Fatema N, Khan MD, et al
    Validation of smear-positive tuberculosis diagnoses in Bangladesh.
    Int J Tuberc Lung Dis. 2016;20:314-8.
    PubMed     Text format     Abstract available


  438. MAHESHWARI P, Chauhan K, Kadam R, Pujani A, et al
    Market assessment of tuberculosis diagnostics in India in 2013.
    Int J Tuberc Lung Dis. 2016;20:304-13.
    PubMed     Text format     Abstract available


  439. ZHAO YL, Pang Y, Xia H, Du X, et al
    Market assessment of tuberculosis diagnostics in China in 2012.
    Int J Tuberc Lung Dis. 2016;20:295-303.
    PubMed     Text format     Abstract available


  440. FURIN J, Alirol E, Allen E, Fielding K, et al
    Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.
    Int J Tuberc Lung Dis. 2016;20:290-4.
    PubMed     Text format     Abstract available


  441. KAPUR A
    Tuberculosis prevention and control: we need to pay heed to diabetes care.
    Int J Tuberc Lung Dis. 2016;20:287.
    PubMed     Text format    


  442. ZUMLA A, Davies PD
    Progress towards achieving global tuberculosis control: so near, yet so far.
    Int J Tuberc Lung Dis. 2016;20:285-6.
    PubMed     Text format    


  443. KOSGEI RJ, Sitienei JK, Kipruto H, Kimenye K, et al
    In reply.
    Int J Tuberc Lung Dis. 2016;20:425-6.
    PubMed     Text format    


  444. HORTON KC, Houben RM, White RG, Corbett EL, et al
    Time for men to count, too.
    Int J Tuberc Lung Dis. 2016;20:425.
    PubMed     Text format    


  445. COWAN J, Michel C, Manhica I, Mutaquiha C, et al
    Remote monitoring of Xpert(R) MTB/RIF testing in Mozambique: results of programmatic implementation of GxAlert.
    Int J Tuberc Lung Dis. 2016;20:335-41.
    PubMed     Text format     Abstract available


    February 2016
  446. SHARMA S, Nahar U, Das A, Radotra B, et al
    Acute respiratory distress syndrome in disseminated tuberculosis: an uncommon association.
    Int J Tuberc Lung Dis. 2016;20:271-5.
    PubMed     Text format     Abstract available


  447. FAN WC, Ou SM, Feng JY, Hu YW, et al
    Increased risk of pulmonary tuberculosis in patients with gastroesophageal reflux disease.
    Int J Tuberc Lung Dis. 2016;20:265-70.
    PubMed     Text format     Abstract available


  448. ZWERLING A, Gomez GB, Pennington J, Cobelens F, et al
    A simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimens.
    Int J Tuberc Lung Dis. 2016;20:257-60.
    PubMed     Text format     Abstract available


  449. CHANDRA TJ, Selvaraj R, Sharma YV
    Same-day sputum smear microscopy for the diagnosis of pulmonary tuberculosis: direct vs. concentrated smear.
    Int J Tuberc Lung Dis. 2016;20:247-51.
    PubMed     Text format     Abstract available


  450. JEENA L, Naidoo K
    Tuberculosis treatment outcomes among peri-urban children receiving doorstep tuberculosis care.
    Int J Tuberc Lung Dis. 2016;20:235-9.
    PubMed     Text format     Abstract available


  451. NGUYEN DT, Bang ND, Hung NQ, Beasley RP, et al
    Yield of chest radiograph in tuberculosis screening for HIV-infected persons at a district-level HIV clinic.
    Int J Tuberc Lung Dis. 2016;20:211-7.
    PubMed     Text format     Abstract available


  452. NLIWASA M, MacPherson P, Mukaka M, Mdolo A, et al
    High mortality and prevalence of HIV and tuberculosis in adults with chronic cough in Malawi: a cohort study.
    Int J Tuberc Lung Dis. 2016;20:202-10.
    PubMed     Text format     Abstract available


  453. HEYSELL SK, Ogarkov OB, Zhdanova S, Zorkaltseva E, et al
    Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, Siberia.
    Int J Tuberc Lung Dis. 2016;20:187-92.
    PubMed     Text format     Abstract available


  454. LEW WJ, Harrington K, Garfin C, Islam T, et al
    Outcomes of Category I and II regimens in mono- and polyresistant tuberculosis cases in the Philippines.
    Int J Tuberc Lung Dis. 2016;20:170-6.
    PubMed     Text format     Abstract available


  455. MAJUMDAR T, Bhattacharya S, Barman D, Bhoumik P, et al
    Detection of multidrug-resistant tuberculosis using MGIT(TM) and MAS-PCR in Tripura, India.
    Int J Tuberc Lung Dis. 2016;20:166-9.
    PubMed     Text format     Abstract available


  456. GEORGHIOU SB, Ajbani K, Rodrigues C, Rodwell TC, et al
    Performance of a pyrosequencing platform in diagnosing drug-resistant extra-pulmonary tuberculosis in India.
    Int J Tuberc Lung Dis. 2016;20:160-5.
    PubMed     Text format     Abstract available


  457. MILLAN-LOU MI, Olle-Goig JE, Tortola MT, Martin C, et al
    Mycobacterial diversity causing multi- and extensively drug-resistant tuberculosis in Djibouti, Horn of Africa.
    Int J Tuberc Lung Dis. 2016;20:150-3.
    PubMed     Text format     Abstract available


  458. BOYLES TH, Kengne AP
    A priori estimation of diagnostic thresholds could improve the reporting of diagnostic studies of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:147-9.
    PubMed     Text format    


  459. MITNICK C, van den Hof S
    Using existing data to illustrate-and close-the gap in access to new anti-tuberculosis drugs.
    Int J Tuberc Lung Dis. 2016;20:145.
    PubMed     Text format    


  460. TAKIFF H, Alame-Emane AK, Pierre-Audigier C, Gicquel B, et al
    In reply.
    Int J Tuberc Lung Dis. 2016;20:282-3.
    PubMed     Text format    


  461. COBELENS F, Gebhard A, van den Hof S
    No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance.
    Int J Tuberc Lung Dis. 2016;20:282.
    PubMed     Text format    


  462. YANG HK, Park MJ, Lee JH, Lee CT, et al
    Incidence of toxic optic neuropathy with low-dose ethambutol.
    Int J Tuberc Lung Dis. 2016;20:261-4.
    PubMed     Text format     Abstract available


  463. SIDIQ Z, Hanif M, Chopra KK, Khanna A, et al
    Random blinded rechecking of AFB smears in a pilot project at an intermediate reference laboratory.
    Int J Tuberc Lung Dis. 2016;20:252-6.
    PubMed     Text format     Abstract available


  464. MBONZE NB, Tabala M, Wenzi LK, Bakoko B, et al
    Xpert((R)) MTB/RIF for smear-negative presumptive TB: impact on case notification in DR Congo.
    Int J Tuberc Lung Dis. 2016;20:240-6.
    PubMed     Text format     Abstract available


  465. SABI I, Kabyemera R, Mshana SE, Kidenya BR, et al
    Pulmonary TB bacteriologically confirmed by induced sputum among children at Bugando Medical Centre, Tanzania.
    Int J Tuberc Lung Dis. 2016;20:228-34.
    PubMed     Text format     Abstract available


  466. ELIAS D, Akuffo H, Abate E, Mekonnen Y, et al
    Risk of tuberculous infection in adolescents and adults in a rural community in Ethiopia.
    Int J Tuberc Lung Dis. 2016;20:218-22.
    PubMed     Text format     Abstract available


  467. KERKHOFF AD, Meintjes G, Opie J, Vogt M, et al
    Anaemia in patients with HIV-associated TB: relative contributions of anaemia of chronic disease and iron deficiency.
    Int J Tuberc Lung Dis. 2016;20:193-201.
    PubMed     Text format     Abstract available


  468. BONNET M, Bastard M, du Cros P, Khamraev A, et al
    Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study.
    Int J Tuberc Lung Dis. 2016;20:177-86.
    PubMed     Text format     Abstract available


  469. NIKAM C, Patel R, Sadani M, Ajbani K, et al
    Redefining MTBDRplus test results: what do indeterminate results actually mean?
    Int J Tuberc Lung Dis. 2016;20:154-9.
    PubMed     Text format     Abstract available


  470. GLAZIOU P, Floyd K, Weil D, Raviglione M, et al
    TB deaths rank alongside HIV deaths as top infectious killer.
    Int J Tuberc Lung Dis. 2016;20:143-4.
    PubMed     Text format    


    January 2016
  471. YANG PL, He XJ, Zang QJ, Li HP, et al
    Association of human leukocyte antigen DRB1 polymorphism and tuberculosis: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:121-8.
    PubMed     Text format     Abstract available


  472. WATANABE A, Matsumoto T, Igari H, Sawa J, et al
    Risk of developing active tuberculosis in rheumatoid arthritis patients on adalimumab in Japan.
    Int J Tuberc Lung Dis. 2016;20:101-8.
    PubMed     Text format     Abstract available


  473. BURMEN B, Modi S, Cavanaugh JS, Muttai H, et al
    Tuberculosis screening outcomes for newly diagnosed persons living with HIV, Nyanza Province, Kenya, 2009.
    Int J Tuberc Lung Dis. 2016;20:79-84.
    PubMed     Text format     Abstract available


  474. AGUILERA XP, Gonzalez C, Najera-De Ferrari M, Hirmas M, et al
    Tuberculosis in prisoners and their contacts in Chile: estimating incidence and latent infection.
    Int J Tuberc Lung Dis. 2016;20:63-70.
    PubMed     Text format     Abstract available


  475. CHEN KS, Liu T, Lin RR, Peng YP, et al
    Tuberculosis transmission and risk factors in a Chinese antimony mining community.
    Int J Tuberc Lung Dis. 2016;20:57-62.
    PubMed     Text format     Abstract available


  476. KIM L, Moonan PK, Heilig CM, Woodruff RS, et al
    Factors associated with recurrent tuberculosis more than 12 months after treatment completion.
    Int J Tuberc Lung Dis. 2016;20:49-56.
    PubMed     Text format     Abstract available


  477. SHULDINER J, Leventhal A, Chemtob D, Mor Z, et al
    Mortality after anti-tuberculosis treatment completion: results of long-term follow-up.
    Int J Tuberc Lung Dis. 2016;20:43-8.
    PubMed     Text format     Abstract available


  478. DOMINGUEZ J, Boettger EC, Cirillo D, Cobelens F, et al
    Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement.
    Int J Tuberc Lung Dis. 2016;20:24-42.
    PubMed     Text format     Abstract available


  479. YATES TA, Tanser F, Abubakar I
    Plan Beta for tuberculosis: it's time to think seriously about poorly ventilated congregate settings.
    Int J Tuberc Lung Dis. 2016;20:5-10.
    PubMed     Text format     Abstract available


  480. SOTGIU G, Centis R, Migliori GB
    Tuberculosis management and determinants of recurrence.
    Int J Tuberc Lung Dis. 2016;20:3.
    PubMed     Text format    


  481. VAN DEN HOF S, Borgdorff MW
    Elevated mortality after successful tuberculosis treatment.
    Int J Tuberc Lung Dis. 2016;20:2.
    PubMed     Text format    


  482. KO Y, Lee HK, Lee YS, Kim MY, et al
    Accuracy of Xpert((R)) MTB/RIF assay compared with AdvanSure TB/NTM real-time PCR using bronchoscopy specimens.
    Int J Tuberc Lung Dis. 2016;20:115-20.
    PubMed     Text format     Abstract available


  483. BENERI CA, Aaron L, Kim S, Jean-Philippe P, et al
    Understanding NIH clinical case definitions for pediatric intrathoracic TB by applying them to a clinical trial.
    Int J Tuberc Lung Dis. 2016;20:93-100.
    PubMed     Text format     Abstract available


  484. KAPOOR S, Gupta A, Shah M
    Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India.
    Int J Tuberc Lung Dis. 2016;20:85-92.
    PubMed     Text format     Abstract available


  485. HENSEL RL, Kempker RR, Tapia J, Oladele A, et al
    Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus.
    Int J Tuberc Lung Dis. 2016;20:71-8.
    PubMed     Text format     Abstract available


    December 2015
  486. MURRAY S, McKenna L, Pelfrene E, Botgros R, et al
    Accelerating clinical drug development for children with tuberculosis.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:69-74.
    PubMed     Text format     Abstract available


  487. TANEJA R, Garcia-Prats AJ, Furin J, Maheshwari HK, et al
    Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerations.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:61-8.
    PubMed     Text format     Abstract available


  488. FURIN J, Mafukidze A, Brigden G, du Cros P, et al
    A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:55-60.
    PubMed     Text format     Abstract available


  489. BASSYOUNI H, Breugelmans JG, Surette M, Olesen O, et al
    Childhood tuberculosis: a unified response to a global problem.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:54.
    PubMed     Text format    


  490. CRUZ AT, Martinez BJ
    Childhood tuberculosis in the United States: shifting the focus to prevention.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:50-3.
    PubMed     Text format     Abstract available


  491. AMANULLAH F, Malik AA
    Unmasking childhood tuberculosis in Pakistan: efforts to improve detection and management.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:47-9.
    PubMed     Text format     Abstract available


  492. SWAMINATHAN S, Sachdeva KS
    Treatment of childhood tuberculosis in India.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:43-6.
    PubMed     Text format     Abstract available


  493. MALECHE-OBIMBO E, Wanjau W, Kathure I
    The journey to improve the prevention and management of childhood tuberculosis: the Kenyan experience.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:39-42.
    PubMed     Text format     Abstract available


  494. MALHOTRA S, Ursu I, Ghoneim R, Jodrey PP, et al
    From availability to uptake: planning for the introduction of new, child-friendly anti-tuberculosis formulations.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:32-8.
    PubMed     Text format     Abstract available


  495. USHERENKO I, Basu Roy U, Mazlish S, Liu S, et al
    Pediatric tuberculosis drug market: an insider perspective on challenges and solutions.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:23-31.
    PubMed     Text format     Abstract available


  496. SCOTT C, Gardiner E, de Lucia A
    The procurement landscape of pediatric tuberculosis treatment: a Global Drug Facility perspective.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:17-22.
    PubMed     Text format     Abstract available


  497. SEDDON JA, Jenkins HE, Liu L, Cohen T, et al
    Counting children with tuberculosis: why numbers matter.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:9-16.
    PubMed     Text format     Abstract available


  498. GRAHAM SM, Grzemska M, Gie RP
    The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:3-8.
    PubMed     Text format     Abstract available


  499. GOOSBY E
    Out of the shadows: shining a light on children with tuberculosis.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:1-2.
    PubMed     Text format    


  500. LAWN SD, Kerkhoff AD
    Rapid diagnosis of TB in HIV-positive in-patients with M. tuberculosis bacteraemia in sub-Saharan Africa.
    Int J Tuberc Lung Dis. 2015;19:1557-9.
    PubMed     Text format    


  501. O'CONNOR BD, Woltmann G, Patel H, Turapov O, et al
    Can resuscitation-promoting factors be used to improve culture rates of extra-pulmonary tuberculosis?
    Int J Tuberc Lung Dis. 2015;19:1556-7.
    PubMed     Text format    


  502. REINA S, Silva C, Gaio AR, Correia AM, et al
    HIV screening in tuberculosis patients in the northern region of Portugal.
    Int J Tuberc Lung Dis. 2015;19:1554-5.
    PubMed     Text format    


  503. ARDIZZONI E, Mulders W, Kotrikadze T, Aspindzelashvili R, et al
    The thin-layer agar method for direct phenotypic detection of multi- and extensively drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1547-52.
    PubMed     Text format     Abstract available


  504. CAUSSE M, Ruiz P, Gutierrez JB, Vaquero M, et al
    New Anyplex II MTB/MDR/XDR kit for detection of resistance mutations in M. tuberculosis cultures.
    Int J Tuberc Lung Dis. 2015;19:1542-6.
    PubMed     Text format     Abstract available


  505. MALHOTRA B, Goyal S, Bhargava S, Reddy PV, et al
    Rapid detection of rifampicin resistance in Mycobacterium tuberculosis by high-resolution melting curve analysis.
    Int J Tuberc Lung Dis. 2015;19:1536-41.
    PubMed     Text format     Abstract available


  506. LORENT N, Kong C, Kim T, Sam S, et al
    Systematic screening for drug-resistant tuberculosis with Xpert((R)) MTB/RIF in a referral hospital in Cambodia.
    Int J Tuberc Lung Dis. 2015;19:1528-35.
    PubMed     Text format     Abstract available


  507. GUNTHER G, van Leth F, Altet N, Dedicoat M, et al
    Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.
    Int J Tuberc Lung Dis. 2015;19:1524-7.
    PubMed     Text format     Abstract available


  508. CRUDU V, Merker M, Lange C, Noroc E, et al
    Nosocomial transmission of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1520-3.
    PubMed     Text format     Abstract available


  509. RAMMA L, Cox H, Wilkinson L, Foster N, et al
    Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa.
    Int J Tuberc Lung Dis. 2015;19:1513-9.
    PubMed     Text format     Abstract available


  510. MORENO-MARTINEZ A, Casals M, Orcau A, Gorrindo P, et al
    Factors associated with diabetes mellitus among adults with tuberculosis in a large European city, 2000-2013.
    Int J Tuberc Lung Dis. 2015;19:1507-12.
    PubMed     Text format     Abstract available


  511. LU MC, Lai CL, Tsai CC, Koo M, et al
    Increased risk of pulmonary and extra-pulmonary tuberculosis in patients with rheumatic diseases.
    Int J Tuberc Lung Dis. 2015;19:1500-6.
    PubMed     Text format     Abstract available


  512. AL-EFRAIJ K, Mota L, Lunny C, Schachter M, et al
    Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:1493-9.
    PubMed     Text format     Abstract available


  513. PAGAOA MA, Royce RA, Chen MP, Golub JE, et al
    Risk factors for transmission of tuberculosis among United States-born African Americans and Whites.
    Int J Tuberc Lung Dis. 2015;19:1485-92.
    PubMed     Text format     Abstract available


  514. CHUNG W, Lee K, Jung Y, Kim Y, et al
    Serum CXCR3 ligands as biomarkers for the diagnosis and treatment monitoring of tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1476-84.
    PubMed     Text format     Abstract available


  515. AMANATIDOU V, Critselis E, Trochoutsou A, Soldatou A, et al
    Interferon gamma inducible protein-10 in the diagnosis of paediatric tuberculosis infection in a low TB incidence country.
    Int J Tuberc Lung Dis. 2015;19:1463-9.
    PubMed     Text format     Abstract available


  516. LU TT, Lin XQ, Zhang L, Cai W, et al
    Magnetic resonance angiography manifestations and prognostic significance in HIV-negative tuberculosis meningitis.
    Int J Tuberc Lung Dis. 2015;19:1448-54.
    PubMed     Text format     Abstract available


  517. WANG Y, Wu JP, Qin GC, Li DY, et al
    Computerised tomography and intravenous pyelography in urinary tuberculosis: a retrospective descriptive study.
    Int J Tuberc Lung Dis. 2015;19:1441-7.
    PubMed     Text format     Abstract available


  518. ALLWOOD BW, Goldin J, Said-Hartley Q, van Zyl-Smit RN, et al
    Assessment of previous tuberculosis status using questionnaires, chest X-rays and computed tomography scans.
    Int J Tuberc Lung Dis. 2015;19:1435-40.
    PubMed     Text format     Abstract available


  519. TRIASIH R, Robertson C, de Campo J, Duke T, et al
    An evaluation of chest X-ray in the context of community-based screening of child tuberculosis contacts.
    Int J Tuberc Lung Dis. 2015;19:1428-34.
    PubMed     Text format     Abstract available


  520. CHANG KC, Yew WW, Sotgiu G
    Clinical research in the treatment of tuberculosis: current status and future prospects.
    Int J Tuberc Lung Dis. 2015;19:1417-27.
    PubMed     Text format     Abstract available


  521. COURTENAY-QUIRK C, Date A, Bachanas P, Baggaley R, et al
    Expanding human immunodeficiency virus testing and counseling to reach tuberculosis clients' partners and families.
    Int J Tuberc Lung Dis. 2015;19:1414-6.
    PubMed     Text format     Abstract available


  522. STOUT JE
    The cost of 'free' tuberculosis care.
    Int J Tuberc Lung Dis. 2015;19:1413.
    PubMed     Text format    


  523. OHKADO A
    How can we sensibly rule out previous episodes of pulmonary tuberculosis disease?
    Int J Tuberc Lung Dis. 2015;19:1412.
    PubMed     Text format    


    November 2015
  524. ABBARA A, Newsholme W, Klein JL, Chambers JB, et al
    Tuberculous endocarditis in an immunocompetent host without miliary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1407-8.
    PubMed     Text format    


  525. SHEN TC, Lin CL, Wei CC, Chen CH, et al
    Previous history of tuberculosis is associated with rheumatoid arthritis.
    Int J Tuberc Lung Dis. 2015;19:1401-5.
    PubMed     Text format     Abstract available


  526. YU SN, Cho OH, Park KH, Jung J, et al
    Late paradoxical lymph node enlargement during and after anti-tuberculosis treatment in non-HIV-infected patients.
    Int J Tuberc Lung Dis. 2015;19:1388-94.
    PubMed     Text format     Abstract available


  527. MANIKA K, Chatzika K, Papaioannou M, Kontou P, et al
    Rifampicin-moxifloxacin interaction in tuberculosis treatment: a real-life study.
    Int J Tuberc Lung Dis. 2015;19:1383-7.
    PubMed     Text format     Abstract available


  528. HATSUDA K, Takeuchi M, Ogata K, Sasaki Y, et al
    The impact of nutritional state on the duration of sputum positivity of Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1369-75.
    PubMed     Text format     Abstract available


  529. KRIEL M, Lotz JW, Kidd M, Walzl G, et al
    Evaluation of a radiological severity score to predict treatment outcome in adults with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1354-60.
    PubMed     Text format     Abstract available


  530. SHARMA A, Musau S, Heilig CM, Okumu AO, et al
    Assessing the effect of decentralisation of laboratory diagnosis for drug-resistant tuberculosis in Kenya.
    Int J Tuberc Lung Dis. 2015;19:1348-53.
    PubMed     Text format     Abstract available


  531. MARANGU D, Devine B, John-Stewart G
    Diagnostic accuracy of nucleic acid amplification tests in urine for pulmonary tuberculosis: a meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:1339-47.
    PubMed     Text format     Abstract available


  532. COLVIN CJ, Leon N, Wills C, van Niekerk M, et al
    Global-to-local policy transfer in the introduction of new molecular tuberculosis diagnostics in South Africa.
    Int J Tuberc Lung Dis. 2015;19:1326-38.
    PubMed     Text format     Abstract available


  533. DOS SANTOS DIAS E, do Prado TN, da Silva Guimaraes AL, Ramos MC, et al
    Childhood tuberculosis and human immunodeficiency virus status in Brazil: a hierarchical analysis.
    Int J Tuberc Lung Dis. 2015;19:1305-11.
    PubMed     Text format     Abstract available


  534. KAWATSU L, Izumi K, Uchimura K, Urakawa M, et al
    Can social network analysis assist in the prioritisation of contacts in a tuberculosis contact investigation?
    Int J Tuberc Lung Dis. 2015;19:1293-9.
    PubMed     Text format     Abstract available


  535. ZHANG Y, Yew WW
    Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015.
    Int J Tuberc Lung Dis. 2015;19:1276-89.
    PubMed     Text format     Abstract available


  536. ZACHARIAH R, Ortuno N, Hermans V, Desalegn W, et al
    Ebola, fragile health systems and tuberculosis care: a call for pre-emptive action and operational research.
    Int J Tuberc Lung Dis. 2015;19:1271-5.
    PubMed     Text format     Abstract available


  537. SLOAN DJ, O'Dempsey TJ
    Tuberculosis in the time of Ebola: obstacles and opportunities.
    Int J Tuberc Lung Dis. 2015;19:1269.
    PubMed     Text format    


  538. TREBUCQ A, Devi S
    Widespread use of Xpert((R)) MTB/RIF will most probably reduce the total number of TB cases notified.
    Int J Tuberc Lung Dis. 2015;19:1406.
    PubMed     Text format    


  539. CRESWELL J, Rai B, Codlin AJ
    In reply.
    Int J Tuberc Lung Dis. 2015;19:1406-7.
    PubMed     Text format    


    October 2015
  540. VOLZ MS, Loddenkemper C, Morguet A, Moos V, et al
    Cardiac myxoma secreting interleukin-6 promotes cavitary tuberculosis: a case report.
    Int J Tuberc Lung Dis. 2015;19:1265-6.
    PubMed     Text format    


  541. NUNN AJ, Phillips PP, Abubakar I
    Reducing relapse in tuberculosis treatment.
    Int J Tuberc Lung Dis. 2015;19:1263-4.
    PubMed     Text format    


  542. GUPTA R, Geiter LJ, Hafkin J, Wells CD, et al
    Delamanid and QT prolongation in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1261-2.
    PubMed     Text format    


  543. PAINTER JA, Posey DL, Phares C
    Tuberculosis misclassification among immigrants.
    Int J Tuberc Lung Dis. 2015;19:1259-60.
    PubMed     Text format    


  544. DENHOLM JT, Matteelli A, Reis A
    In reply. Promoting ethical and evidence-based policies for latent tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1258-9.
    PubMed     Text format    


  545. LI N, Xie WP, Kong H, Min R, et al
    Enrichment of regulatory T-cells in blood of patients with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1230-8.
    PubMed     Text format     Abstract available


  546. KAMBLI P, Ajbani K, Nikam C, Khillari A, et al
    Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations.
    Int J Tuberc Lung Dis. 2015;19:1227-9.
    PubMed     Text format     Abstract available


  547. ELMARAACHLI W, Slater M, Berrada ZL, Lin SY, et al
    Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.
    Int J Tuberc Lung Dis. 2015;19:1222-6.
    PubMed     Text format     Abstract available


  548. KIM YW, Seong MW, Kim TS, Yoo CG, et al
    Evaluation of Xpert((R)) MTB/RIF assay: diagnosis and treatment outcomes in rifampicin-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1216-21.
    PubMed     Text format     Abstract available


  549. TU HZ, Lin YE, Tseng MR, Huang TS, et al
    Cost-effective identification of Mycobacterium tuberculosis complex using microscopic morphology and rapid tests.
    Int J Tuberc Lung Dis. 2015;19:1204-8.
    PubMed     Text format     Abstract available


  550. ADELMAN MW, Tsegaye M, Kempker RR, Alebachew T, et al
    Intensified tuberculosis case finding among HIV-infected persons using a WHO symptom screen and Xpert((R)) MTB/RIF.
    Int J Tuberc Lung Dis. 2015;19:1197-203.
    PubMed     Text format     Abstract available


  551. REIS-SANTOS B, Pellacani-Posses I, Macedo LR, Golub JE, et al
    Directly observed therapy of tuberculosis in Brazil: associated determinants and impact on treatment outcome.
    Int J Tuberc Lung Dis. 2015;19:1188-93.
    PubMed     Text format     Abstract available


  552. VALENCA MS, Scaini JL, Abileira FS, Goncalves CV, et al
    Prevalence of tuberculosis in prisons: risk factors and molecular epidemiology.
    Int J Tuberc Lung Dis. 2015;19:1182-7.
    PubMed     Text format     Abstract available


  553. KOSGEI RJ, Sitienei JK, Kipruto H, Kimenye K, et al
    Gender differences in treatment outcomes among 15-49 year olds with smear-positive pulmonary tuberculosis in Kenya.
    Int J Tuberc Lung Dis. 2015;19:1176-81.
    PubMed     Text format     Abstract available


  554. KAMPER-JORGENSEN Z, Carstensen B, Norredam M, Bygbjerg IC, et al
    Diabetes-related tuberculosis in Denmark: effect of ethnicity, diabetes duration and year of diagnosis.
    Int J Tuberc Lung Dis. 2015;19:1169-75.
    PubMed     Text format     Abstract available


  555. SHIDAM UG, Roy G, Sahu SK, Kumar SV, et al
    Screening for diabetes among presumptive tuberculosis patients at a tertiary care centre in Pondicherry, India.
    Int J Tuberc Lung Dis. 2015;19:1163-8.
    PubMed     Text format     Abstract available


  556. MUKHERJEE A, Khandelwal D, Singla M, Lodha R, et al
    Outcomes of Category II anti-tuberculosis treatment in Indian children.
    Int J Tuberc Lung Dis. 2015;19:1153-7.
    PubMed     Text format     Abstract available


  557. CHIANG SS, Roche S, Contreras C, Alarcon V, et al
    Barriers to the diagnosis of childhood tuberculosis: a qualitative study.
    Int J Tuberc Lung Dis. 2015;19:1144-52.
    PubMed     Text format     Abstract available


  558. MASON PH, Degeling C, Denholm J
    Sociocultural dimensions of tuberculosis: an overview of key concepts.
    Int J Tuberc Lung Dis. 2015;19:1135-43.
    PubMed     Text format     Abstract available


  559. SOTGIU G, Matteelli A, Migliori GB
    Diabetes and tuberculosis: what else beyond?
    Int J Tuberc Lung Dis. 2015;19:1127-8.
    PubMed     Text format    


  560. STEVENSON DR, Biswas JR, Lievesley A, Quinn G, et al
    False-positive Xpert((R)) MTB/RIF more than seven years after cure.
    Int J Tuberc Lung Dis. 2015;19:1264-5.
    PubMed     Text format    


  561. EVANS TB, Mador MJ, Glick M
    In reply.
    Int J Tuberc Lung Dis. 2015;19:1260-1.
    PubMed     Text format    


  562. NOESKE J
    Sovereignty or dignity?
    Int J Tuberc Lung Dis. 2015;19:1258.
    PubMed     Text format    


  563. FURIN J, Harausz E, Zimetbaum P, Cox H, et al
    In reply. QTc prolongation and delamanid: access and safety.
    Int J Tuberc Lung Dis. 2015;19:1262-3.
    PubMed     Text format    


  564. JOHNSTON JC, Khan FA, Dowdy DW
    In reply.
    Int J Tuberc Lung Dis. 2015;19:1264.
    PubMed     Text format    


    September 2015
  565. ATRE S
    Notification of multidrug-resistant tuberculosis cases and treatment outcomes in the private sector.
    Int J Tuberc Lung Dis. 2015;19:1126.
    PubMed     Text format    


  566. RATNAPPULI A, Collinson S, Gaspar-Garcia E, Richardson L, et al
    Pott's disease in twenty-first century London: spinal tuberculosis as a continuing cause of morbidity and mortality.
    Int J Tuberc Lung Dis. 2015;19:1125-6.
    PubMed     Text format    


  567. SUEN SC, Bendavid E, Goldhaber-Fiebert JD
    Cost-effectiveness of improvements in diagnosis and treatment accessibility for tuberculosis control in India.
    Int J Tuberc Lung Dis. 2015;19:1115-24.
    PubMed     Text format     Abstract available


  568. CHOI Y, Hong SR, Jeon BY, Wang HY, et al
    Conventional and real-time PCR targeting 16S ribosomal RNA for the detection of Mycobacterium tuberculosis complex.
    Int J Tuberc Lung Dis. 2015;19:1102-8.
    PubMed     Text format     Abstract available


  569. HEO EY, Choi NK, Yang BR, Koo BK, et al
    Tuberculosis is frequently diagnosed within 12 months of diabetes mellitus.
    Int J Tuberc Lung Dis. 2015;19:1098-101.
    PubMed     Text format     Abstract available


  570. TOGUN TO, Egere U, Sillah AK, Ayorinde A, et al
    Contribution of Xpert((R)) MTB/RIF to the diagnosis of pulmonary tuberculosis among TB-exposed children in The Gambia.
    Int J Tuberc Lung Dis. 2015;19:1091-7.
    PubMed     Text format     Abstract available


  571. PAGE AL, Ardizzoni E, Lassovsky M, Kirubi B, et al
    Routine use of Xpert((R)) MTB/RIF in areas with different prevalences of HIV and drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1078-83.
    PubMed     Text format     Abstract available


  572. BASU I, Bower JE, Henderson GK, Lowe O, et al
    False-negative BD MGIT TBc Identification Test results in routine tuberculosis diagnosis: a New Zealand perspective.
    Int J Tuberc Lung Dis. 2015;19:1073-5.
    PubMed     Text format     Abstract available


  573. HERNANDEZ P, Punchak M, Camacho M, Hepple P, et al
    Investigating the quality of expectorated sputum for tuberculosis diagnosis in Bolivia.
    Int J Tuberc Lung Dis. 2015;19:1065-7.
    PubMed     Text format     Abstract available


  574. GARFEIN RS, Collins K, Munoz F, Moser K, et al
    Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study.
    Int J Tuberc Lung Dis. 2015;19:1057-64.
    PubMed     Text format     Abstract available


  575. SITIENEI J, Kipruto H, Mansour O, Ndisha M, et al
    Correlates of default from anti-tuberculosis treatment: a case study using Kenya's electronic data system.
    Int J Tuberc Lung Dis. 2015;19:1051-6.
    PubMed     Text format     Abstract available


  576. SALYER SJ, Fitter DL, Milo R, Blanton C, et al
    Evaluation of the national tuberculosis surveillance program in Haiti.
    Int J Tuberc Lung Dis. 2015;19:1045-50.
    PubMed     Text format     Abstract available


  577. MORALES-GARCIA C, Parra-Ruiz J, Sanchez-Martinez JA, Delgado-Martin AE, et al
    Concomitant tuberculosis and lung cancer diagnosed by bronchoscopy.
    Int J Tuberc Lung Dis. 2015;19:1027-32.
    PubMed     Text format     Abstract available


  578. DEDICOAT M, Lange C
    Tuberculosis preventive chemotherapy: the times they are a-changin'.
    Int J Tuberc Lung Dis. 2015;19:1002.
    PubMed     Text format    


    August 2015
  579. REMASCHI G, Venturini E, Romano F, Perrone A, et al
    A rare cause of osteomyelitis with a rare genetic mutation: when Mycobacterium doesn't only mean tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:999-1000.
    PubMed     Text format    


  580. JOON D, Nimesh M, Saluja D
    Loop-mediated isothermal amplification as alternative to PCR for the diagnosis of extra-pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:986-91.
    PubMed     Text format     Abstract available


  581. NDJEKA N, Conradie F, Schnippel K, Hughes J, et al
    Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis.
    Int J Tuberc Lung Dis. 2015;19:979-85.
    PubMed     Text format     Abstract available


  582. DU TOIT E, Squire SB, Dunbar R, Machekano R, et al
    Comparing multidrug-resistant tuberculosis patient costs under molecular diagnostic algorithms in South Africa.
    Int J Tuberc Lung Dis. 2015;19:960-8.
    PubMed     Text format     Abstract available


  583. ASANTE-POKU A, Otchere ID, Danso E, Mensah DD, et al
    Evaluation of GenoType((R)) MTBDRplus for the rapid detection of drug-resistant tuberculosis in Ghana.
    Int J Tuberc Lung Dis. 2015;19:954-9.
    PubMed     Text format     Abstract available


  584. HIRSCH-MOVERMAN Y, Cronin WA, Chen B, Moran JA, et al
    HIV counseling and testing in tuberculosis contact investigations in the United States and Canada.
    Int J Tuberc Lung Dis. 2015;19:943-53.
    PubMed     Text format     Abstract available


  585. LAI CC, Lee MT, Lee SH, Lee SH, et al
    Risk of incident active tuberculosis and use of corticosteroids.
    Int J Tuberc Lung Dis. 2015;19:936-42.
    PubMed     Text format     Abstract available


  586. KAWATSU L, Uchimura K, Kobayashi M, Ishikawa N, et al
    Overview of the tuberculosis burden in prison institutions in Japan, 2000-2012.
    Int J Tuberc Lung Dis. 2015;19:921-6.
    PubMed     Text format     Abstract available


  587. IWATA K, Doi A, Nakamura T, Yoshida H, et al
    The validity of three sputum smears taken in one day for discontinuing isolation of tuberculosis patients.
    Int J Tuberc Lung Dis. 2015;19:918-20.
    PubMed     Text format     Abstract available


  588. SHETE PB, Haguma P, Miller CR, Ochom E, et al
    Pathways and costs of care for patients with tuberculosis symptoms in rural Uganda.
    Int J Tuberc Lung Dis. 2015;19:912-7.
    PubMed     Text format     Abstract available


  589. SLOAN DJ, Mwandumba HC, Kamdolozi M, Shani D, et al
    Vitamin D deficiency in Malawian adults with pulmonary tuberculosis: risk factors and treatment outcomes.
    Int J Tuberc Lung Dis. 2015;19:904-11.
    PubMed     Text format     Abstract available


  590. JERENE D, Melese M, Kassie Y, Alem G, et al
    The yield of a tuberculosis household contact investigation in two regions of Ethiopia.
    Int J Tuberc Lung Dis. 2015;19:898-903.
    PubMed     Text format     Abstract available


  591. HARRIES AD, Kumar AM, Satyanarayana S, Lin Y, et al
    Diabetes mellitus and tuberculosis: programmatic management issues.
    Int J Tuberc Lung Dis. 2015;19:879-86.
    PubMed     Text format     Abstract available


  592. DAVIES PD, Martineau AR
    Vitamin D and tuberculosis: more effective in prevention than treatment?
    Int J Tuberc Lung Dis. 2015;19:876-7.
    PubMed     Text format    


  593. DAVIES PD
    Towards the elimination of tuberculosis and a reduction in chest diseases.
    Int J Tuberc Lung Dis. 2015;19:875.
    PubMed     Text format    


    July 2015
  594. VOLZ MS, Epple HJ, Schneider T
    Immune reconstitution inflammatory syndrome after BCG infection mimicking miliary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:873-4.
    PubMed     Text format    


  595. BALAJEE KL, Rizwan SA, Kulkarni V, Silan V, et al
    Fixed-dose combination drugs for the treatment of tuberculosis under India's RNTCP.
    Int J Tuberc Lung Dis. 2015;19:870-1.
    PubMed     Text format    


  596. KOWADA A
    Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke.
    Int J Tuberc Lung Dis. 2015;19:857-63.
    PubMed     Text format     Abstract available


  597. ROBERTS-WITTEVEEN A, Reinten T, Christensen A, Sintchenko V, et al
    Multidrug-resistant tuberculosis in New South Wales, Australia, 1999-2010: a case series report.
    Int J Tuberc Lung Dis. 2015;19:850-6.
    PubMed     Text format     Abstract available


  598. LI CP, Zhou Y, Xiang X, Zhou Y, et al
    Relationship of HLA-DRB1 gene polymorphism with susceptibility to pulmonary tuberculosis: updated meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:841-9.
    PubMed     Text format     Abstract available


  599. KAMUDUMULI PS, Beylis N, Blann L, Duse A, et al
    Molecular typing of drug-susceptible and -resistant Mycobacterium tuberculosis in Johannesburg, South Africa.
    Int J Tuberc Lung Dis. 2015;19:834-40.
    PubMed     Text format     Abstract available


  600. JUBULIS J, Dionne K, Osterhout G, Ayuk L, et al
    Mycobacterium tuberculosis resistance in pulmonary TB patients in Cameroon: a phenotypic susceptibility assay.
    Int J Tuberc Lung Dis. 2015;19:823-7.
    PubMed     Text format     Abstract available


  601. RIENTHONG S, Boonin C, Chaiyasirinrote B, Satproedprai N, et al
    Evaluation of a novel line-probe assay for genotyping-based diagnosis of Mycobacterium tuberculosis in Thailand.
    Int J Tuberc Lung Dis. 2015;19:817-22.
    PubMed     Text format     Abstract available


  602. DE LA MORA IL, Martinez-Oceguera D, Laniado-Laborin R
    Chronic airway obstruction after successful treatment of tuberculosis and its impact on quality of life.
    Int J Tuberc Lung Dis. 2015;19:808-10.
    PubMed     Text format     Abstract available


  603. HEMANTH KUMAR AK, Narendran G, Kumar RS, Ramachandran G, et al
    RMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatment.
    Int J Tuberc Lung Dis. 2015;19:805-7.
    PubMed     Text format     Abstract available


  604. JONNALAGADDA S, LaCourse SM, Otieno P, Lohman-Payne B, et al
    Incidence and correlates of tuberculosis IGRA conversion among HIV-infected postpartum women.
    Int J Tuberc Lung Dis. 2015;19:792-8.
    PubMed     Text format     Abstract available


  605. ZHANG XL, Li SG, Li HT, Li GX, et al
    Integrating tuberculosis screening into annual health examinations for the rural elderly improves case detection.
    Int J Tuberc Lung Dis. 2015;19:787-91.
    PubMed     Text format     Abstract available


  606. DAWSON R, Narunsky K, Carman D, Gupte N, et al
    Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:780-6.
    PubMed     Text format     Abstract available


  607. GAO Z, Parhar A, Gallant V, Heffernan C, et al
    A population-based study of tuberculosis case fatality in Canada: do Aboriginal peoples fare less well?
    Int J Tuberc Lung Dis. 2015;19:772-9.
    PubMed     Text format     Abstract available


  608. LIEW SM, Khoo EM, Ho BK, Lee YK, et al
    Tuberculosis in Malaysia: predictors of treatment outcomes in a national registry.
    Int J Tuberc Lung Dis. 2015;19:764-71.
    PubMed     Text format     Abstract available


  609. SATYANARAYANA S, Subbaraman R, Shete P, Gore G, et al
    Quality of tuberculosis care in India: a systematic review.
    Int J Tuberc Lung Dis. 2015;19:751-63.
    PubMed     Text format     Abstract available


  610. ADAMS CD, Velez JD, Martinez LF
    Xpert((R)) MTB/RIF and very low positive detection in bronchoalveolar lavage: diagnostic concerns.
    Int J Tuberc Lung Dis. 2015;19:871-3.
    PubMed     Text format    


  611. SIMONS SO, van der Laan T, de Zwaan R, Kamst M, et al
    Molecular drug susceptibility testing in the Netherlands: performance of the MTBDRplus and MTBDRsl assays.
    Int J Tuberc Lung Dis. 2015;19:828-33.
    PubMed     Text format     Abstract available


  612. HANRAHAN CF, Clouse K, Bassett J, Mutunga L, et al
    The patient impact of point-of-care vs. laboratory placement of Xpert((R)) MTB/RIF.
    Int J Tuberc Lung Dis. 2015;19:811-6.
    PubMed     Text format     Abstract available


  613. BISHARA H, Ore L, Vinitsky O, Bshara H, et al
    Cost of nurse-managed latent tuberculous infection treatment among hard-to-reach immigrants in Israel.
    Int J Tuberc Lung Dis. 2015;19:799-804.
    PubMed     Text format     Abstract available


    June 2015
  614. BABLISHVILI N, Tukvadze N, Avaliani Z, Blumberg HM, et al
    A comparison of the Xpert((R)) MTB/RIF and GenoType((R)) MTBDRplus assays in Georgia.
    Int J Tuberc Lung Dis. 2015;19:676-8.
    PubMed     Text format     Abstract available


  615. MCCARTHY KM, Scott LE, Gous N, Tellie M, et al
    High incidence of latent tuberculous infection among South African health workers: an urgent call for action.
    Int J Tuberc Lung Dis. 2015;19:647-53.
    PubMed     Text format     Abstract available


    May 2015
  616. RASHID ALI MR, Parameswaran U, William T, Bird E, et al
    A prospective study of mycobacterial viability in refrigerated, unpreserved sputum batched for up to 8 weeks.
    Int J Tuberc Lung Dis. 2015;19:620-1.
    PubMed     Text format    


  617. MUNN MS, Duchin JS, Kay M, Pecha M, et al
    Analysis of risk factors for tuberculous infection following exposure at a homeless shelter.
    Int J Tuberc Lung Dis. 2015;19:570-5.
    PubMed     Text format     Abstract available


  618. SUBEDI P, Drezner KA, Dogbey MC, Newbern EC, et al
    Evaluation of latent tuberculous infection and treatment completion for refugees in Philadelphia, PA, 2010-2012.
    Int J Tuberc Lung Dis. 2015;19:565-9.
    PubMed     Text format     Abstract available


  619. KUABAN C, Noeske J, Rieder HL, Ait-Khaled N, et al
    High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.
    Int J Tuberc Lung Dis. 2015;19:517-24.
    PubMed     Text format     Abstract available


  620. YEW WW, Chiang CY, Lumb R, Islam T, et al
    Are pulmonary non-tuberculous mycobacteria of concern in the Western Pacific Region?
    Int J Tuberc Lung Dis. 2015;19:499-500.
    PubMed     Text format    


    April 2015
  621. REVES RR
    In reply.
    Int J Tuberc Lung Dis. 2015;19:495.
    PubMed     Text format    


  622. BOYLES TH, Hughes J, Cox V, Burton R, et al
    False-positive Xpert((R)) MTB/RIF assays and previous treatment.
    Int J Tuberc Lung Dis. 2015;19:495-6.
    PubMed     Text format    


  623. PHILLIPS PP, Lipman MC
    Safe and effective treatment for patients with isoniazid drug resistance.
    Int J Tuberc Lung Dis. 2015;19:494-5.
    PubMed     Text format    


  624. ZELLWEGER JP, Bodmer T, Bischler U, Mykychak M, et al
    Implementation of the Stop TB strategy in a large TB hospital in Ukraine: achievements and deficiencies.
    Int J Tuberc Lung Dis. 2015;19:493-4.
    PubMed     Text format    


  625. HESSELING AC, Jaspan HB, Black GF, Nene N, et al
    Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination.
    Int J Tuberc Lung Dis. 2015;19:454-62.
    PubMed     Text format     Abstract available


  626. KUMAR P, Kumar P, Balooni V, Singh S, et al
    Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India.
    Int J Tuberc Lung Dis. 2015;19:434-9.
    PubMed     Text format     Abstract available


  627. VAN DEN HANDEL T, Hampton KH, Sanne I, Stevens W, et al
    The impact of Xpert((R)) MTB/RIF in sparsely populated rural settings.
    Int J Tuberc Lung Dis. 2015;19:392-8.
    PubMed     Text format     Abstract available


  628. YIM JJ, Koh WJ
    MDR-TB recurrence after successful treatment: additional studies using molecular genotyping are needed.
    Int J Tuberc Lung Dis. 2015;19:371.
    PubMed     Text format    


    March 2015
  629. STEINGART KR, Schiller I, Dendukuri N
    In reply to 'False-positive Xpert(R) MTB/RIF assays in previously treated patients'.
    Int J Tuberc Lung Dis. 2015;19:366-7.
    PubMed     Text format    


  630. HOGER S, Lykens K, Beavers S, Katz D, et al
    In reply.
    Int J Tuberc Lung Dis. 2015;19:367-8.
    PubMed     Text format    


  631. ZHANG H, Zhang JQ, Zhong XN, Liu GN, et al
    Two case reports of Castleman disease with pulmonary involvement.
    Int J Tuberc Lung Dis. 2015;19:362-5.
    PubMed     Text format     Abstract available


  632. PARK SJ, Jo KW, Yoo B, Lee CK, et al
    Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy.
    Int J Tuberc Lung Dis. 2015;19:342-8.
    PubMed     Text format     Abstract available


  633. WANG HF, Wang R, O'Gorman M, Crownover P, et al
    Bioequivalence of fixed-dose combination RIN(R)-150 to each reference drug in loose combination.
    Int J Tuberc Lung Dis. 2015;19:333-8.
    PubMed     Text format     Abstract available


  634. MOYENGA I, Roggi A, Sulis G, Diande S, et al
    The impact of Xpert(R) MTB/RIF depends on service coordination: experience in Burkina Faso.
    Int J Tuberc Lung Dis. 2015;19:285-7.
    PubMed     Text format     Abstract available


  635. BOYLES TH, Thwaites GE
    Appropriate use of the Xpert(R) MTB/RIF assay in suspected tuberculous meningitis.
    Int J Tuberc Lung Dis. 2015;19:276-7.
    PubMed     Text format     Abstract available


  636. LIPPINCOTT CK, Miller MB, Van Rie A, Weber DJ, et al
    The complexities of Xpert(R) MTB/RIF interpretation.
    Int J Tuberc Lung Dis. 2015;19:273-5.
    PubMed     Text format     Abstract available


  637. RIEDER HL
    Jean-Antoine Villemin: ending an Alpine divide.
    Int J Tuberc Lung Dis. 2015;19:253.
    PubMed     Text format    


    February 2015
  638. SOLOMONS RS, Goussard P, Visser DH, Marais BJ, et al
    Chest radiograph findings in children with tuberculous meningitis.
    Int J Tuberc Lung Dis. 2015;19:200-4.
    PubMed     Text format     Abstract available


  639. LOVEDAY M, Wallengren K, Brust J, Roberts J, et al
    Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.
    Int J Tuberc Lung Dis. 2015;19:163-71.
    PubMed     Text format     Abstract available


  640. COLEMAN M, Finney LJ, Komrower D, Chitani A, et al
    Markers to differentiate between Kaposi's sarcoma and tuberculous pleural effusions in HIV-positive patients.
    Int J Tuberc Lung Dis. 2015;19:144-50.
    PubMed     Text format     Abstract available


  641. DENHOLM JT, Matteelli A, Reis A
    Latent tuberculous infection: ethical considerations in formulating public health policy.
    Int J Tuberc Lung Dis. 2015;19:137-40.
    PubMed     Text format     Abstract available


    January 2015
  642. ZISHIRI V, Chihota V, McCarthy K, Charalambous S, et al
    Pooling sputum from multiple individuals for Xpert(R) MTB/RIF testing: a strategy for screening high-risk populations.
    Int J Tuberc Lung Dis. 2015;19:87-90.
    PubMed     Text format     Abstract available


  643. SOLOMONS RS, Visser DH, Friedrich SO, Diacon AH, et al
    Improved diagnosis of childhood tuberculous meningitis using more than one nucleic acid amplification test.
    Int J Tuberc Lung Dis. 2015;19:74-80.
    PubMed     Text format     Abstract available


  644. YUEN CM, Krapivina TM, Kazennyy BY, Kiryanova EV, et al
    Annual risk of tuberculous infection measured using serial skin testing, Orel Oblast, Russia, 1991-2005.
    Int J Tuberc Lung Dis. 2015;19:39-43.
    PubMed     Text format     Abstract available


  645. HIRSCH-MOVERMAN Y, Shrestha-Kuwahara R, Bethel J, Blumberg HM, et al
    Latent tuberculous infection in the United States and Canada: who completes treatment and why?
    Int J Tuberc Lung Dis. 2015;19:31-8.
    PubMed     Text format     Abstract available


    November 2014
  646. FRICK M, Seaworth B, McKenna L, Elnour T, et al
    Cost-effectiveness of 12-dose LTBI regimen improved following advocacy to lower the price of rifapentine.
    Int J Tuberc Lung Dis. 2014;18:1386.
    PubMed     Text format    


    August 2014
  647. MARTINSON NA, McLeod KE, Milovanovic M, Msandiwa R, et al
    Implementation of isoniazid preventive therapy for HIV-infected adults: overstatement of district reports.
    Int J Tuberc Lung Dis. 2014;18:1005.
    PubMed     Text format    


  648. SANTUCCI N, Diaz A, Bianchi E, Spinelli S, et al
    Leptin does not enhance cell-mediated immune responses following mycobacterial antigen stimulation.
    Int J Tuberc Lung Dis. 2014;18:981-7.
    PubMed     Text format     Abstract available


  649. MAREKOVIC I, Bosnjak Z, Plecko V
    Direct identification of mycobacteria from smear-positive samples using real-time polymerase chain reaction.
    Int J Tuberc Lung Dis. 2014;18:978-80.
    PubMed     Text format     Abstract available


  650. SHIVARAMAKRISHNA HR, Frederick A, Shazia A, Murali L, et al
    Isoniazid preventive treatment in children in two districts of South India: does practice follow policy?
    Int J Tuberc Lung Dis. 2014;18:919-24.
    PubMed     Text format     Abstract available


  651. BAMRAH S, Brostrom R, Dorina F, Setik L, et al
    Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012.
    Int J Tuberc Lung Dis. 2014;18:912-8.
    PubMed     Text format     Abstract available


  652. BONFIGLIOLI KR, Ribeiro AC, Moraes JC, Saad CG, et al
    LTBI screening in rheumatoid arthritis patients prior to anti-TNF treatment in an endemic area.
    Int J Tuberc Lung Dis. 2014;18:905-11.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: